(ROOT
  (S
    (NP
      (NP (NN Sex) (NN hormone) (NN modulation))
      (PP (IN of)
        (NP
          (NP (NN cell) (NN growth)
            (CC and)
            (NNS apoptosis))
          (PP (IN of)
            (NP (DT the) (JJ human) (NN monocytic/macrophage) (NN cell))))))
    (VP (VBP line)
      (SBAR
        (S
          (NP (NNP Abstract) (NN Sex) (NNS hormones))
          (VP (VBP seem)
            (S
              (VP (TO to)
                (VP (VB modulate)
                  (NP (DT the) (JJ immune/inflammatory) (NNS responses))
                  (PP (IN by)
                    (NP
                      (NP (JJ different) (NNS mechanisms))
                      (PP (IN in)
                        (NP
                          (ADJP (JJ female)
                            (CC and)
                            (NN male))
                          (JJ rheumatoid) (NN arthritis) (NNS patients))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NNS effects))
      (PP (IN of)
        (UCP
          (ADJP (JJ 17β-oestradiol))
          (CC and)
          (PP (IN of)
            (NP (NN testosterone))))))
    (VP (VBD were)
      (VP (VBN tested)
        (PP (IN on)
          (NP
            (NP (DT the) (JJ cultured) (JJ human) (NN monocytic/macrophage) (NN cell) (NN line))
            (PRN (-LRB- -LRB-)
              (NP (NNP THP-1))
              (-RRB- -RRB-))
            (VP (VBN activated)
              (PP (IN with)
                (S
                  (VP (VBG IFN-γ)
                    (SBAR (IN in) (NN order)
                      (S
                        (VP (TO to)
                          (VP (VB investigate)
                            (NP (PRP$ their) (NN role))
                            (PP (IN in)
                              (NP (NN cell) (NN proliferation)
                                (CC and)
                                (NNS apoptosis)))))))))))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Activated) (JJ human) (NN THP-1) (NNS cells))
    (VP (VBD were)
      (VP (VBN cultured)
        (PP (IN in)
          (NP
            (NP (DT the) (NN presence))
            (PP (IN of)
              (NP
                (NP
                  (ADJP (JJ 17β-oestradiol)
                    (CC and)
                    (JJ testosterone)))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (JJ final) (NN concentration))
                    (, ,)
                    (NP (CD 10) (NN nM)))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN evaluation))
      (PP (IN of)
        (NP
          (NP (NNS markers))
          (PP (IN of)
            (NP (NN cell) (NN proliferation))))))
    (VP (VBD included)
      (NP
        (NP (DT the) (NNP NF-κB) (NNP DNA-binding) (NN assay))
        (, ,)
        (NP (DT the) (JJ NF-κB) (NN inhibition) (NN complex))
        (, ,)
        (NP (DT the) (JJ proliferating) (NN cell) (JJ nuclear) (NN antigen) (NN expression))
        (CC and)
        (NP (DT the) (JJ methyl-tetrazolium) (NN salt) (NN test))))
    (. .)))

(ROOT
  (S
    (NP (NNS Apoptosis))
    (VP (VBD was)
      (VP (VBN detected)
        (PP
          (PP (IN by)
            (NP (DT the) (JJ annexin) (JJ V-propidium) (NN assay)))
          (CC and)
          (PP (IN by)
            (NP (DT the) (JJ cleaved) (JJ poly-ADP) (NN ribose) (NN polymerase) (NN expression))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Specific) (NNS methods))
    (VP (VBD included)
      (SBAR
        (S
          (NP (NN flow) (NN analysis))
          (ADVP (RB cytometry))
          (VP (VBP scatter)
            (NP (NN analysis) (, ,) (NN immunocytochemistry)
              (CC and)
              (JJ western) (NN blot) (NN analysis))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Cell) (NN growth) (NN inhibition))
      (CC and)
      (NP (VBN increased) (NNS apoptosis)))
    (VP (VBD were)
      (VP (VBN observed)
        (PP (IN in)
          (NP (JJ testosterone-treated) (NN THP-1) (NNS cells)))))
    (. .)))

(ROOT
  (S
    (NP (VBN Increased) (NN poly-ADP))
    (VP
      (VP (VBP ribose)
        (NP (JJ polymerase-cleaved) (NN expression)))
      (CC and)
      (VP (VBD decreased)
        (NP (VBG proliferating) (NN cell)))
      (NP
        (NP (JJ nuclear) (NN antigen) (NN expression))
        (, ,)
        (CONJP (RB as) (RB well) (IN as))
        (NP
          (NP
            (NP (DT an) (NN increase))
            (PP (IN of)
              (NP (NNP IκB-α))))
          (CC and)
          (NP
            (NP (DT a) (NN decrease))
            (PP (IN of)
              (NP
                (NP (DT the)
                  (ADJP (RB IκB-α) (JJ phosphorylated))
                  (NN form))
                (PRN (-LRB- -LRB-)
                  (NP
                    (QP (CD ser) (CD 32)))
                  (-RRB- -RRB-)))))))
      (, ,)
      (VP (VBD were)
        (VP (VBN found)
          (PP (IN in)
            (NP (JJ testosterone-treated) (NN THP-1) (NNS cells))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (DT the) (NNP NF-κB) (NNP DNA) (NNP binding))
    (VP (VBD was)
      (VP (VBN found)
        (S
          (VP (VBN increased)
            (PP (IN in)
              (NP (JJ 17β-oestradiol-treated) (NN THP-1) (NNS cells)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN treatment))
      (PP (IN with)
        (NP
          (NP (NN staurosporine))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (NN enhancer))
              (PP (IN of)
                (NP (NNS apoptosis))))
            (-RRB- -RRB-))
          (VP (VBN induced)))))
    (VP (VBD decreased)
      (S
        (NP (NNP NF-κB) (NNP DNA))
        (ADJP (JJ binding)
          (PP
            (PP (IN in)
              (NP (DT all) (NNS conditions)))
            (, ,)
            (CC but)
            (RB particularly)
            (PP (IN in)
              (NP (JJ testosterone-treated) (NN THP-1) (NNS cells)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Treatment))
      (PP (IN of)
        (NP
          (NP (NN THP-1))
          (PP (IN by)
            (NP (NN sex) (NNS hormones))))))
    (VP
      (VP (VBD was)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB influence)
                (NP (NN cell) (NN proliferation)))))))
      (CC and)
      (VP (VBZ apoptosis)))
    (. .)))

(ROOT
  (S
    (S
      (NP (NNS Androgens))
      (VP (VBD were)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB increase)
                (NP (DT the) (NNS apoptosis))))))))
    (, ,)
    (CC and)
    (S
      (NP (NNS oestrogens))
      (VP (VBD showed)
        (NP (DT a) (JJ protective) (NN trend))
        (PP (IN on)
          (NP (NN cell) (NN death)))
        (: --)
        (NP
          (NP (DT both))
          (VP (VBG acting)
            (PP (IN as)
              (NP
                (NP (NNS modulators))
                (PP (IN of)
                  (NP (DT the) (JJ NF-κB) (NN complex)))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Introduction) (NNP Experimental))
      (CC and)
      (NP (JJ clinical) (NN evidence)))
    (VP (VBZ indicates)
      (SBAR (IN that)
        (S
          (NP (JJ immune) (NN reactivity))
          (VP
            (VP (VBZ is)
              (ADJP
                (ADJP (JJR greater))
                (PP (IN in)
                  (NP (NNS females))))
              (PP (IN than)
                (PP (IN in)
                  (NP (NNS males)))))
            (CC and)
            (VP (VBZ suggests)
              (SBAR (IN that)
                (S
                  (NP (JJ gonadal) (NNS steroids))
                  (VP (MD may)
                    (VP (VB play)
                      (NP (DT an) (JJ important) (NN role))
                      (PP (IN in)
                        (NP
                          (NP (DT the) (NN regulation))
                          (PP (IN of)
                            (NP
                              (NP (DT the) (JJ immune) (NN response))
                              (VP (VBG -LSB-)
                                (NP (CD 1-4) (NNS -RSB-))))))))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Indeed))
    (, ,)
    (NP
      (NP (JJ many) (NNS cells))
      (PP (IN of)
        (NP (DT the) (JJ immune) (NN system))))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB possess)
                (NP
                  (ADJP (JJ functional)
                    (NP
                      (NP (NN sex) (NN hormone) (NNS receptors))
                      (, ,)
                      (PP (JJ such) (IN as)
                        (NP
                          (NP (NNP CD8-positive) (NNP T) (NNS cells))
                          (, ,)
                          (NP (NNP B) (NNS cells))
                          (CC and)
                          (PRN (, ,)
                            (ADVP (RB notably))
                            (, ,))
                          (NP (NNS monocytes/macrophages))))))
                  (NNS -LSB-))
                (NP
                  (QP (CD 5,6) (CD -RSB-)))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Therefore))
    (, ,)
    (NP
      (NP (JJ 17β-oestradiol))
      (PRN (-LRB- -LRB-)
        (NP (NNP E2))
        (-RRB- -RRB-)))
    (VP (VBD was)
      (VP (VBN found)
        (S
          (VP
            (VP (TO to)
              (VP (VB inhibit)
                (NP (JJ cellular) (NNS apoptosis))))
            (, ,)
            (VP (TO to)
              (VP (VB increase)
                (NP (NN antibody) (NN production))
                (PP (IN by)
                  (NP (NNP B) (NNS cells)))))
            (CC and)
            (VP (TO to)
              (VP (VB exert)
                (NP (JJ dose-related) (NNS effects))
                (PP (IN on)
                  (NP
                    (NP (JJ T-cell) (NNS functions))
                    (VP (VBG -LSB-)
                      (NP (CD 7) (NNS -RSB-)))))))))))
    (. .)))

(ROOT
  (S
    (NP (NNS Androgens))
    (VP (VBP seem)
      (S
        (VP (TO to)
          (VP (VB exert)
            (NP (NNS effects))
            (PP (IN opposite)
              (PP (TO to)
                (NP
                  (NP (DT those))
                  (PP (IN of)
                    (NP (NNP E2))))))
            (PP (IN on)
              (NP
                (NP (JJ immune) (NN response))
                (VP (VBG -LSB-)
                  (NP
                    (QP (CD 8) (CD -RSB-))))))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Clinical) (NN epidemiology))
    (ADVP (RB clearly))
    (VP (VBZ confirms)
      (NP
        (NP (DT a) (JJR higher) (NN prevalence))
        (PP (IN of)
          (NP
            (NP (JJ autoimmune) (NNS diseases))
            (PP (IN in)
              (NP (JJ female) (NNS subjects)))))
        (SBAR
          (WHADVP (WRB when))
          (S
            (PP (VBN compared)
              (PP (IN with)
                (NP (JJ male) (NNS subjects))))
            (NP (NNP -LSB-) (CD 9))
            (VP (VBZ -RSB-))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (NP (DT The) (NNS studies))
        (PP (VBG concerning)
          (NP
            (NP
              (NP (DT the)
                (ADJP (JJ functional))
                (NN interaction))
              (PP (IN between)
                (NP (DT the) (JJ NF-κB) (NN pathway))))
            (CC and)
            (NP
              (NP (NNS members))
              (PP (IN of)
                (NP (DT the) (JJ steroid) (NN hormone) (NN receptor) (NN family)))))))
      (, ,)
      (CC and)
      (NP
        (NP (PRP$ their) (NN role))
        (PP (IN in)
          (NP (JJ synovial) (NN inflammation))))
      (, ,))
    (VP (VBP have)
      (VP (VBN advanced)
        (ADVP (RB significantly))
        (, ,)
        (SBAR (IN although) (IN with)
          (S
            (NP (JJ controversial) (NNS results))
            (VP (VBZ -LSB-)
              (NP (CD 10,11) (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (ADJP (JJ particular)))
    (, ,)
    (PP (IN after)
      (NP
        (NP (VBG binding))
        (PP (IN with)
          (NP (NNP E2)))))
    (, ,)
    (NP (NN oestrogen) (NNS receptors))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN shown)
          (S
            (VP (TO to)
              (VP (VB interact)
                (PP (IN with)
                  (S
                    (NP
                      (NP (JJ NF-κB) (NNS factors))
                      (, ,)
                      (PP (IN via)
                        (NP (JJ transcriptional) (NNS co-factors)))
                      (, ,))
                    (VP (VBG resulting)
                      (PP (IN in)
                        (NP (JJ mutual)
                          (CC or)
                          (JJ non-mutual) (NN antagonism))))))))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Other) (NNS studies))
    (VP (VBP hypothesize)
      (SBAR (IN that) (, ,)
        (S
          (SBAR (IN since)
            (S
              (NP (NN oestrogen) (NNS receptors))
              (VP (MD may)
                (VP (VB repress)
                  (NP (DT both)
                    (ADJP (JJ constitutive)
                      (CC and)
                      (JJ inducible))
                    (JJ NF-κB) (NN activity))))))
          (, ,)
          (NP
            (NP (DT the) (NN overexpression))
            (PP (IN of)
              (NP
                (NP (JJ NF-κB-inducible) (NNS genes))
                (PP (IN in)
                  (NP (JJ oestrogen) (JJ receptor-negative) (NNS cells))))))
          (VP (MD might)
            (VP (VB contribute)
              (PP (TO to)
                (NP (JJ malignant) (NN cell) (NN growth)
                  (CC and)
                  (JJ chemotherapeutic) (NN resistance) (NNS -LSB-)))
              (NP
                (QP (CD 12,13) (CD -RSB-))))))))
    (. .)))

(ROOT
  (S
    (PP (IN On)
      (NP (DT the) (NN contrary)))
    (, ,)
    (NP (JJ further) (NNS studies))
    (VP (VBP report)
      (SBAR (IN that)
        (S
          (NP (NNP E2))
          (VP (VBZ blocks)
            (NP
              (NP (DT the) (JJ transcriptional) (NN activity))
              (PP (IN of)
                (NP (CD p65))))
            (PP (IN in)
              (NP
                (NP (NNS macrophages))
                (VP (VBG -LSB-)
                  (NP (CD 14) (NNS -RSB-)))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB However))
    (, ,)
    (NP (DT these) (JJ opposite) (NNS observations))
    (VP (VBP arise)
      (S
        (VP (VBG using)
          (NP
            (NP
              (NP
                (NP (JJ different) (NN cell) (NNS lines))
                (PRN (-LRB- -LRB-)
                  (NP (NNS human/animals))
                  (-RRB- -RRB-)))
              (CC and)
              (NP (NN culture) (NNS conditions)))
            (CONJP (RB as) (RB well) (IN as))
            (NP
              (NP (JJ different) (NN hormone) (NNS concentrations))
              (NP
                (QP (CD -LSB-) (CD 15))
                (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP
      (NP (JJ multiple) (NNS mechanisms))
      (PP (VBG concerning)
        (NP
          (NP (DT the) (NN interaction))
          (PP (IN between)
            (NP (NN oestrogen) (NNS receptors)
              (CC and)
              (NNS NF-κB))))))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN proposed) (, ,)
          (PP (JJ such) (IN as)
            (NP
              (NP
                (NP (NN repression))
                (PP (IN of)
                  (NP (NNP NF-κB) (NNP DNA)
                    (ADJP (JJ binding)
                      (PP (IN by)
                        (NP
                          (NP (JJ physical) (NN association))
                          (PP (IN with)
                            (NP (NN oestrogen))))))
                    (NNS receptors))))
              (CC and)
              (NP
                (NP (DT the) (NN regulation))
                (PP (IN of)
                  (NP
                    (NP (JJ IκB-α) (NN expression))
                    (PP (IN by)
                      (NP
                        (NP (NNS oestrogens))
                        (VP (VBG -LSB-)
                          (NP (CD 16,17) (NNS -RSB-)))))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN androgen) (NN receptor))
    (VP (VBZ seems)
      (S
        (VP (TO to)
          (VP (VB be)
            (ADJP (RB closely) (VBN related)
              (PP (TO to)
                (NP
                  (NP (DT the) (JJ glucocorticoid) (NN receptor))
                  (PP (IN in)
                    (NP
                      (NP (NNS terms))
                      (PP (IN of)
                        (NP (DT both) (NN structure)
                          (CC and)
                          (NN sequence) (NN homology))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (DT The) (NN androgen) (NN receptor))
        (CC and)
        (NP (DT the) (JJ glucocorticoid) (NN receptor)))
      (VP
        (VP (VBP have)
          (VP (VBN been)
            (VP (VBN shown)
              (S
                (VP (TO to)
                  (VP (VB interact)))))))
        (CC and)
        (VP (VBZ repress)
          (NP (NN activator) (NN protein) (CD 1))
          (PP (IN via)
            (NP (DT a) (JJ similar) (NN mechanism))))))
    (: ;)
    (S
      (ADVP (RB consequently))
      (, ,)
      (NP (PRP it))
      (VP (MD would) (RB not)
        (VP (VB be)
          (ADJP (JJ surprising))
          (SBAR (IN that)
            (S
              (NP (DT the) (NN androgen) (NN receptor))
              (VP (MD might)
                (ADVP (RB also))
                (VP (VB interact)
                  (PP (IN with)
                    (NP
                      (NP (NNP NF-κB))
                      (PP (IN in)
                        (NP
                          (NP (DT a) (NN manner))
                          (ADJP (RB very) (JJ similar))))))
                  (PP (TO to)
                    (NP (DT that)
                      (ADJP (JJ observed)
                        (PP (IN for)
                          (NP (DT the) (JJ glucocorticoid) (NN receptor))))
                      (JJ -LSB-) (CD 18) (NNS -RSB-))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT Both)
      (NP (DT the) (NN androgen) (NN receptor))
      (CC and)
      (NP (NNP NF-κB)))
    (VP (VBP are)
      (NP
        (NP (JJ inducible) (NN transcription) (NNS factors))
        (PP (IN with)
          (NP
            (NP (DT some) (VBG opposing) (NNS functions))
            (PP (IN in)
              (NP
                (NP (DT the) (NN regulation))
                (PP (IN of)
                  (NP
                    (NP
                      (ADJP (JJ immune)
                        (CC and)
                        (JJ inflammatory))
                      (NNS responses))
                    (ADJP (JJ -LSB-)
                      (NP (CD 19) (NNS -RSB-)))))))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (PRP It))
      (VP (VBZ is)
        (ADJP (JJ possible))
        (SBAR (IN that)
          (S
            (NP
              (NP (JJ inflammatory) (NNS agents))
              (SBAR
                (WHNP (WDT that))
                (S
                  (VP (VBP activate)
                    (NP
                      (NP (NNP NF-κB))
                      (PP (IN in)
                        (NP (NN vivo))))))))
            (VP (MD may)
              (VP (VB interfere)
                (PP (IN with)
                  (NP (JJ normal) (NN androgen) (NN signalling)))))))))
    (, ,)
    (CC and)
    (S
      (NP (JJ recent) (NNS studies))
      (VP (VBP indicate)
        (SBAR (IN that)
          (S
            (NP
              (NP (DT the) (JJ androgen) (NN receptor)
                (CC and)
                (NN NF-κB))
              (PRN (-LRB- -LRB-)
                (NP (NN subunit) (CD p65))
                (-RRB- -RRB-)))
            (VP (VBP are)
              (NP
                (NP (JJ mutual) (JJ transcriptional) (NNS antagonists))
                (VP (VBG -LSB-)
                  (NP (CD 20) (NNS -RSB-)))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (JJ present) (NN study))
    (VP (VBD was)
      (ADVP (RB therefore))
      (VP (VBN undertaken)
        (S
          (VP (TO to)
            (VP (VB examine)
              (NP
                (NP (DT the)
                  (ADJP
                    (ADJP (JJ long-term))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (NN time) (NN course))
                        (PP (IN of)
                          (NP (CD 7) (NNS days))))
                      (-RRB- -RRB-)))
                  (NNS effects))
                (PP (IN of)
                  (NP (NN sex) (NNS hormones))))
              (PP (IN on)
                (NP
                  (NP
                    (ADJP (RB activated) (JJ cultured))
                    (JJ human) (NN monocytic/macrophage) (NN cell) (NN line)
                    (PRN (-LRB- -LRB-)
                      (NP (NNP THP-1))
                      (-RRB- -RRB-))
                    (NNS cells))
                  (PP (IN by)
                    (S
                      (VP (VBG investigating)
                        (NP (PRP$ their) (NNS effects))
                        (PP (IN on)
                          (NP (NN cell) (NN proliferation)
                            (CC and)
                            (NNS apoptosis)))))))))))))
    (. .)))

(ROOT
  (SINV
    (S
      (NP (DT These) (NNS cells))
      (VP
        (VP (VBP are)
          (VP (VBN equipped)
            (PP (IN with)
              (NP (JJ functional) (NN sex) (NN hormone) (NNS receptors)))))
        (CC and)
        (VP (VBP are)
          (NP
            (NP (DT an) (JJ important) (NN target))
            (PP (IN of)
              (NP (NN sex)))))))
    (VP (VBD steroid))
    (NP
      (NP (NNS hormones))
      (PRN (, ,)
        (ADVP (RB particularly))
        (PP (IN in)
          (NP (JJ inflammatory) (NNS diseases))))
      (PP (JJ such) (IN as)
        (NP (JJ rheumatoid) (NN arthritis)))
      (PRN (-LRB- -LRB-)
        (NP (NNP RA))
        (-RRB- -RRB-))
      (VP (VBG -LSB-)
        (NP (CD 21) (NNS -RSB-))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (ADJP (JJ particular)))
    (, ,)
    (PP (IN in)
      (NP (DT the) (JJ present) (NN study)))
    (NP (PRP we))
    (VP (VBD used)
      (NP
        (NP
          (NP (JJ pharmacological) (NNS concentrations))
          (PP (IN of)
            (NP (NNP E2))))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (JJ final) (NN concentration))
            (, ,)
            (NP (CD 10) (NN nM))
            (, ;)
            (NP (NNP Sigma-Aldrich))
            (, ,)
            (NP (NNP Milan))
            (, ,)
            (NP (NNP Italy)))
          (-RRB- -RRB-))
        (SBAR
          (WHNP (WDT that))
          (S
            (VP (VBP have)
              (VP (VBN been)
                (VP
                  (ADVP (RB already))
                  (VBN described)
                  (PP (IN as)
                    (NP (DT the)
                      (ADJP
                        (ADJP (RBS most) (JJ efficient))
                        (PP (IN in)
                          (S
                            (VP (VBG stimulating)
                              (NP (NNS macrophages))
                              (PP (IN in)
                                (ADJP (NN vitro) (JJ -LSB-)))))))
                      (QP (CD 22) (CD -RSB-)))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Accordingly))
    (, ,)
    (NP (DT the) (JJ same) (NN concentration))
    (VP (VBZ has)
      (VP (VBN been)
        (VP (VBN used)
          (PP (IN for)
            (NP (JJ testosterone) (NNP -LSB-) (CD 23) (NNS -RSB-))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (ADVP (RB therefore))
    (VP (VBD investigated)
      (NP (NN sex) (NN hormone) (NNS effects))
      (PP (IN on)
        (NP (DT the) (JJ NF-κB) (NN pathway)))
      (, ,)
      (PP (IN as)
        (NP
          (NP (DT a) (NN complex))
          (PP (IN of)
            (NP
              (NP (NNS molecules))
              (VP (VBG modulating)
                (NP
                  (NP (JJ cellular) (NNS responses))
                  (PP (IN in)
                    (NP (VBN activated) (NNS cells))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNS Materials)
        (CC and)
        (NNS methods) (NN THP-1) (NNS cells))
      (PRN (-LRB- -LRB-)
        (NP
          (NP (NNP Interlab) (NN cell) (NN line) (NN collection) (NNP HTL097014))
          (: ;)
          (NP (NNP IST) (NNP c/o) (NNP CBA)))
        (, ,)
        (NP
          (NP (NNP Genoa))
          (, ,)
          (NP (NNP Italy)))
        (-RRB- -RRB-)))
    (VP (VBD were)
      (VP (VBN cultured)
        (PP (IN in)
          (NP
            (NP (NN RPMI-1640) (NN medium))
            (VP (VBN supplemented)
              (PP (IN with)
                (NP
                  (NP
                    (NP
                      (ADJP (CD 2) (NN %))
                      (JJ foetal) (JJ bovine) (NN serum))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP Sigma-Aldrich))
                      (-RRB- -RRB-)))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP
                        (ADJP (CD 5) (NN %))
                        (JJ CO2) (JJ humidified) (NN atmosphere))
                      (PP (IN at)
                        (NP (CD 37) (NN °) (NNP C))))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Moreover))
    (, ,)
    (NP
      (NP (DT the) (NN absence))
      (PP (IN of)
        (NP
          (NP (VBG binding))
          (PP (IN of)
            (NP
              (NP (DT the) (NNS hormones))
              (PP (IN with)
                (NP
                  (NP (JJ other) (JJ foetal) (JJ bovine) (NN serum) (NNS components))
                  (VP (VBN related)
                    (PP (TO to)
                      (NP
                        (NP (NN growth) (NN rate))
                        (CC and)
                        (NP
                          (NP (DT the) (NN survival))
                          (PP (IN of)
                            (NP (JJ cultured) (NN THP-1) (NNS cells))))))
                    (PP (IN over)
                      (NP
                        (NP (DT the) (NN course))
                        (PP (IN of)
                          (NP (CD 7) (NNS days)))))))))))))
    (VP (VBD were)
      (VP (VBN investigated)))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNS cells))
    (VP (VBD were)
      (VP (VBN maintained)
        (PP (IN in)
          (NP (JJ logarithmic) (NN growth)))
        (PP (IN by)
          (NP
            (NP
              (NP (NN passage))
              (NP
                (QP (DT every) (CD 3))))
            (: --)
            (NP (CD 4) (NNS days))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN viability))
      (PP (IN of)
        (NP
          (NP (DT the) (NNS cells))
          (PRN (-LRB- -LRB-)
            (NP
              (NP (CD 97))
              (: --)
              (NP (CD 98) (NN %)))
            (-RRB- -RRB-)))))
    (VP (VBD was)
      (VP (VBN tested)
        (PP (IN by)
          (NP (DT the) (NNP Trypan) (JJ blue) (NN exclusion) (NN procedure)))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Briefly))
    (, ,)
    (NP (DT the) (NNS cells))
    (VP
      (VP (VBD were)
        (VP (VBN seeded)
          (PP (IN into)
            (NP
              (NP (JJ six-well) (JJ flat-bottom) (NNS plates))
              (PRN (-LRB- -LRB-)
                (NP (CD 106) (NN cells/well))
                (-RRB- -RRB-))))))
      (CC and)
      (VP (VBD were)
        (VP (VBN treated)
          (PP (IN with)
            (NP
              (NP (CD 500) (JJ U/ml) (NNS IFN-γ))
              (PRN (-LRB- -LRB-)
                (NP (NNP Sigma-Aldrich))
                (-RRB- -RRB-))))
          (SBAR (IN in) (NN order)
            (S
              (VP (TO to)
                (VP (VB differentiate)
                  (NP (NN THP-1))
                  (PP (IN into)
                    (NP
                      (NP (JJ macrophage) (NNS cells))
                      (VP (VBG -LSB-)
                        (NP (CD 24) (NNS -RSB-))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN activation)
        (CC and)
        (NN transformation))
      (PP (IN of)
        (NP (DT the) (NNS cells))))
    (VP (VBD was)
      (VP (VBN evaluated)
        (PP (IN by)
          (NP
            (NP
              (NP (DT the) (NN expression))
              (PP (IN of)
                (NP (JJ different) (NN macrophage) (NNS antigens))))
            (: :)
            (NP
              (NP (NNP CD68) (, ,) (NNP CD14) (, ,) (NNP HAM) (CD 56))
              (, ,)
              (NP (NNP Mac) (CD 387)))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (CD THP-1) (VBN activated) (NNS cells))
    (VP (VBD were)
      (ADVP (RB then))
      (NP
        (NP
          (ADJP (JJ incubated)
            (PP (IN for))
            (NP (CD 24) (, ,) (CD 48) (, ,) (CD 72) (, ,) (CD 96)
              (CC and)
              (CD 168)))
          (NNS hours))
        (PP (IN with)
          (NP (NN E2)
            (CC and)
            (NN testosterone)))
        (PRN (-LRB- -LRB-)
          (NP
            (QP (CD 10) (CD nM)))
          (-RRB- -RRB-))))
    (. .)))

(ROOT
  (SINV
    (PP (IN After)
      (NP
        (NP (DT that) (NN time) (NNS samples))
        (PP (IN of)
          (NP (NN THP-1) (NNS cells)))))
    (VP (VBD were)
      (VP
        (ADVP (RB also))
        (VBN treated)
        (PP (IN with)
          (NP (DT an) (JJ apoptosis) (NN inducer) (NN -LSB-)))))
    (NP
      (NP (CD 25) (NNS -RSB-))
      (, ,)
      (NP
        (NP (NN staurosporine))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (CD 17) (NN nM))
            (: ;)
            (NP (NNP Sigma) (NNP Aldrich)))
          (-RRB- -RRB-))
        (, ,)
        (PP (IN for)
          (NP (CD 24) (NNS hours)))))
    (. .)))

(ROOT
  (S
    (PP (IN At)
      (NP
        (NP (DT the) (NN end))
        (PP (IN of)
          (NP (DT the) (JJ different) (NN incubation) (NNS times)))))
    (, ,)
    (NP (DT the) (NNS cells))
    (VP (VBD were)
      (VP
        (VP (VBN harvested))
        (, ,)
        (VP (VBN washed)
          (PP (IN in)
            (NP
              (NP
                (NP (NNP Dulbecco) (POS 's))
                (JJ phosphate-buffered) (NN saline))
              (PRN (-LRB- -LRB-)
                (NP (NNP DPBS))
                (-RRB- -RRB-)))))
        (CC and)
        (VP (VBN treated)
          (PP (IN with)
            (NP
              (NP (JJ different) (NNS lysis) (NNS buffers))
              (PP (IN for)
                (NP (DT the) (JJ nuclear)
                  (CC and)
                  (JJ total) (NN protein) (NN extraction))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NN Part))
      (PP (IN of)
        (NP (DT the) (NN cell))))
    (VP (VBD was)
      (ADVP (RB then))
      (VP (VBN collected)
        (PP (IN for)
          (NP (NNP DNA) (NNP content)
            (PRN (-LRB- -LRB-)
              (NP (JJ normal)
                (CC and)
                (JJ apoptotic))
              (-RRB- -RRB-))
            (NN evaluation)))
        (PP
          (PP (IN by)
            (NP
              (NP (NN flow) (NN analysis))
              (JJ cytometry) (NN scatter) (NN analysis)))
          (CC and)
          (PP (IN for)
            (NP (JJ immunocytochemistry) (NN analysis))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (JJ immunocytochemistry) (NN analysis)
      (S
        (VP (TO to)
          (VP (VB evaluate)
            (NP
              (NP (DT the) (NN expression))
              (PP (IN of)
                (NP (NNP CD68) (, ,) (NNP CD14) (, ,) (NNP HAM56)
                  (CC and)
                  (NNP Mac387))))
            (PP (IN in)
              (NP (DT the) (JJ treated) (NNS cells)))))))
    (VP (VBD showed)
      (NP
        (NP (JJ positive) (NNS results))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (NNS data))
            (VP (RB not) (VBN shown)))
          (-RRB- -RRB-)))
      (, ,)
      (S
        (VP (VBG confirming)
          (NP
            (NP (DT the) (NN activation))
            (PP (IN of)
              (NP (NNS monocytes))))
          (PP (IN by)
            (NP (NNP IFN-γ))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN cell) (NN growth))
    (VP (VBD was)
      (VP (VBN evaluated)
        (PP (IN at)
          (NP (JJ different) (NNS times)))
        (PP (IN by)
          (NP
            (NP (DT the) (JJ methyl-tetrazolium) (NN salt) (NN test))
            (, ,)
            (SBAR
              (WHNP (WDT which))
              (S
                (VP (VBZ represents)
                  (NP (DT a) (JJ quantitative) (JJ colorimetric) (NN assay))
                  (S
                    (VP (TO to)
                      (VP (VB detect)
                        (NP (NN cell) (NN survival)
                          (CC and)
                          (NN proliferation))))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN test))
    (VP (VBZ is)
      (VP (VBN based)
        (PP (IN on)
          (NP
            (NP (DT the) (NN ability))
            (PP (IN of)
              (NP (NN living) (NNS cells)))))
        (S
          (VP (TO to)
            (VP (VB cleave)
              (NP (DT the) (NN tetrazolium) (NN ring))
              (PP (IN at)
                (NP
                  (NP (DT the) (NN level))
                  (PP (IN of)
                    (NP (JJ active) (NN mitochondria))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Briefly))
    (, ,)
    (NP (DT the) (NNS cells))
    (VP
      (VP (VBD were)
        (VP (VBN seeded)
          (PP (IN into)
            (NP (JJ 96-well) (NN microtitre) (NNS plates)))))
      (CC and)
      (VP (VBD were)
        (VP (VBN treated)
          (PP (VBG according)
            (PP (TO to)
              (NP (DT the) (JJ experimental) (NN design)))))))
    (. .)))

(ROOT
  (S
    (PP (IN At)
      (NP (DT the) (JJ established) (NN time)))
    (, ,)
    (S
      (FRAG
        (NP
          (NP (CD 50) (NN μl) (JJ methyl-tetrazolium) (NN salt) (NN labelling) (NN reagent) (NNS -LSB-))
          (NP (CD 3)))
        (: -)
        (NP
          (NP (-LRB- -LRB-) (JJ 4,5-dimethylthiazol-2-yl) (-RRB- -RRB-) (NN -2,5))
          (: -)
          (NP (NN diphenyltetrazolium) (NN bromide))))
      (, ,)
      (NP
        (NP (CD 5) (NN mg/ml))
        (PP (IN in)
          (NP (NNP PBS) (NNP -RSB-))))
      (VP (VBD was)
        (VP (VBN added)
          (PP (TO to)
            (NP (DT each) (NN well))))))
    (CC and)
    (S
      (S
        (VP (VBN incubated)
          (PP (IN in)
            (NP (JJ humidified) (NN atmosphere)))
          (PP (IN at)
            (NP
              (QP (CD 37) (CD °)))
            (NP
              (NP (NNP C.))
              (ADVP
                (NP (CD Four) (NNS hours))
                (RBR later))))))
      (, ,)
      (NP (CD 100) (NN μl) (NN dimethylsulfoxide))
      (VP (VBD were)
        (VP
          (VP (VBN introduced)
            (PP (IN into)
              (NP (DT each) (NN well))))
          (CC and)
          (VP (VBN mixed)
            (ADVP (RB thoroughly))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN absorbance))
    (VP (VBD was)
      (VP (VBN calculated)
        (PP (IN at)
          (NP
            (NP
              (QP (CD 540) (CD nm)))
            (, ,)
            (VP (VBG using)
              (NP (DT a) (JJ scanning) (JJ multiwell) (NN spectrophotometer)))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Standard) (NNS curves))
    (VP (VBD were)
      (VP (VBN constructed)
        (PP (IN for)
          (NP
            (NP (NN THP-1) (NNS cells))
            (VP (VBG using)
              (S
                (VP (VBN known)
                  (NP (VBG plating) (NNS densities))
                  (, ,)
                  (S
                    (VP (VBG allowing)
                      (NP (DT the) (NN cell) (NN number))
                      (S
                        (VP (TO to)
                          (VP (VB be)
                            (VP (VBN calculated)
                              (PP (IN from)
                                (NP (DT this) (JJ optical) (NN density) (NN reading))))))))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT Each) (NN experiment))
    (VP (VBD was)
      (VP (VBN performed)
        (PP (IN in)
          (NP (NN triplicate)))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (JJ apoptotic) (NNS events))
    (VP (VBD were)
      (VP (VBN evaluated)
        (PP (IN after)
          (NP
            (NP (CD 168) (NNS hours))
            (PP (IN from)
              (NP
                (NP (DT both) (NN sex) (NN hormone) (NN stimulation)
                  (CC and)
                  (NN staurosporine) (NN treatment))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (CD 17) (NN nM))
                    (PP (IN for)
                      (NP (CD 24) (NNS hours))))
                  (-RRB- -RRB-))))))
        (PP (IN by)
          (NP
            (NP (JJ annexin) (JJ V-propidium) (NN iodide) (NN analysis))
            (PRN (-LRB- -LRB-)
              (NP (NNP MBL) (NNP Co.))
              (, ,)
              (NP (NNP Ltd))
              (, ,)
              (NP (NNP Nagoya) (, ,) (NNP Japan))
              (-RRB- -RRB-))))
        (, ,)
        (SBAR (IN in) (NN order)
          (S
            (VP (TO to)
              (VP (VB detect)
                (NP
                  (NP
                    (NP (DT the) (JJ early-stage) (NNS apoptosis))
                    (PRN (-LRB- -LRB-)
                      (S
                        (NP (NNS cells))
                        (ADJP (RB only) (JJ annexin-positive)))
                      (-RRB- -RRB-)))
                  (CC and)
                  (NP
                    (NP (DT the) (JJ late-stage) (NNS apoptosis))
                    (PRN (-LRB- -LRB-)
                      (NP (NNS cells) (NN annexin-positive)
                        (CC and)
                        (NN propidium-positive))
                      (-RRB- -RRB-))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (S
        (VP (VBG resuspending)
          (NP
            (NP (DT the) (NNS cells))
            (PRN (-LRB- -LRB-)
              (NP (CD 1) (NNP ×) (NNS 105))
              (-RRB- -RRB-)))
          (PP (IN into)
            (NP
              (NP (CD 200) (NN μl))
              (PP (IN of)
                (NP
                  (ADJP
                    (NP (CD 1) (NNS x))
                    (JJ binding))
                  (NN buffer))))))))
    (, ,)
    (NP
      (NP (CD 1) (JJ μl) (JJ fluorescein-labelled) (NN annexin) (NNS V))
      (CC and)
      (NP (CD 1) (NN μl) (NN propidium) (NN iodide)))
    (VP (VBD were)
      (VP (VBN added)))
    (. .)))

(ROOT
  (S (RB Then)
    (NP (DT the) (NNS cells))
    (VP (VBD were)
      (VP (VBN incubated)
        (PP (IN for)
          (NP
            (NP (CD 5) (NN min))
            (PP (IN at)
              (NP
                (NP (NN room) (NN temperature))
                (PRN (-LRB- -LRB-)
                  (NP (JJ dark) (NN light))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Finally))
    (, ,)
    (NP (DT the) (NNS cells))
    (VP (VBD were)
      (VP
        (VP (VBN plated)
          (PP (IN on)
            (NP (NN glass) (NNS slides))))
        (CC and)
        (VP (VBN analysed)
          (PP (IN by)
            (NP
              (NP
                (NP (JJ fluorescence) (NN microscopy))
                (PRN (-LRB- -LRB-)
                  (NP
                    (QP (CD 550) (CD nm)))
                  (-RRB- -RRB-)))
              (PP (IN for)
                (NP
                  (NP (DT a) (NN total))
                  (PP (IN of)
                    (NP
                      (NP (CD 500) (NNS cells))
                      (PP (IN per)
                        (NP (NN sample)))))))
              (, ,)
              (SBAR
                (WHNP (WDT which))
                (S
                  (VP (VBZ allows)
                    (NP
                      (NP (NN detection) (RB even))
                      (PP (IN of)
                        (NP (DT a) (JJ single) (JJ apoptotic) (NN cell))))))))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB confirm)
          (NP (DT the) (VBN reduced) (NN DNA) (NN content)))))
    (PRN (-LRB- -LRB-)
      (S
        (NP (NN oligonucleosomal-size))
        (VP (VBZ fragments)))
      (-RRB- -RRB-))
    (NP
      (NP (DT the) (NNS cells))
      (VP (VBN stimulated)
        (PP (IN with)
          (NP (NNS hormones)))
        (, ,)
        (PP (IN without)
          (CC and)
          (IN with)
          (NP (NN staurosporine)))
        (, ,)
        (PP (IN after)
          (NP (NN fixation)))))
    (VP
      (VP (VBD were)
        (VP (VBN stained)
          (PP (IN with)
            (NP
              (NP (VBG intercalating) (NNS dyes))
              (PRN (-LRB- -LRB-)
                (NP (NN propidium) (NN iodide))
                (-RRB- -RRB-))))))
      (CC and)
      (VP (VBD were)
        (VP (VBN analysed)
          (PP (IN by)
            (NP
              (NP (NN flow) (NN analysis) (NN cytometry) (NN scatter))
              (PRN (-LRB- -LRB-)
                (NP (NNP Becton-Dickinson-Immunocytometry) (NNP Systems))
                (, ,)
                (NP (NNP Erembodegem))
                (, ,)
                (NP (NNP Belgium))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (SINV
    (S
      (NP (NN THP-1) (NNS cells))
      (VP (VBD were)
        (VP (VBN harvested)
          (PP (IN at)
            (NP
              (NP (DT a) (NN concentration))
              (PP (IN of)
                (NP
                  (QP (CD 5) (CD ×))
                  (CD 103)))
              (, ,)
              (VP (VBG being)
                (VP (VBN sedimented)
                  (PP (IN on)
                    (NP (JJ poly-L-lysine-coated) (NN glass))))))))))
    (VP (VBZ slides)
      (PP (IN for)
        (NP
          (NP (CD 40) (NN min))
          (PP (IN at)
            (NP (CD 4))))))
    (NP (NNP °) (NNP C))
    (. .)))

(ROOT
  (SINV
    (S
      (NP (DT The) (NNS spots))
      (VP (VBD were)
        (ADVP (RB then))
        (VP (VBN air-dried)
          (CC and)
          (VBN fixed)
          (PP (IN in)
            (NP
              (NP (JJ cold) (NN acetone))
              (PP (IN for)
                (NP (CD 30))))))))
    (VP
      (VP (VBZ s))
      (, ,)
      (CC and)
      (VP (VBN stored)
        (PP (IN at)
          (NP (NNP -20) (NNP °) (NNP C)))
        (PP (IN until)
          (NP
            (NP (DT the) (NN immunodetermination))
            (PP (IN of)
              (NP
                (NP (JJ poly-ADP) (NN ribose) (NN polymerase))
                (PRN (-LRB- -LRB-)
                  (NP (NNP PARP))
                  (-RRB- -RRB-))
                (: -)
                (NP
                  (NP (JJ cleaved) (NN expression))
                  (, ,)
                  (NP
                    (NP (VBG proliferating) (NN cell) (JJ nuclear) (NN antigen))
                    (PRN (-LRB- -LRB-)
                      (NP (NNP PCNA))
                      (-RRB- -RRB-))))))))))
    (NP
      (NP (NN expression))
      (, ,)
      (NP
        (NP (NNP NF-κB) (, ,) (NNP IκB-α)
          (CC and)
          (NNP IκB-α-ser))
        (NP
          (NP (CD 32))
          (PRN (-LRB- -LRB-)
            (NP (NNP Santa) (NNP Cruz) (NNP Biotechnology))
            (, ,)
            (NP (NNP Santa) (NNP Cruz))
            (, ,)
            (NP (NNP CA) (, ,) (NNP USA))
            (-RRB- -RRB-)))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (NP
        (NP (NN rehydration))
        (PP (IN in)
          (NP (NNP PBS)))))
    (, ,)
    (NP (NNS spots))
    (VP (VBD were)
      (VP (VBN incubated)
        (PP (IN with)
          (NP
            (NP (DT the) (JJ anti-human) (NN antibody))
            (PP (IN at)
              (NP (JJ different) (NNS dilutions)))))
        (PP (IN at)
          (NP (NN room) (NN temperature)))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (JJ second)
      (CC and)
      (JJ third) (NNS steps))
    (VP (VBD were)
      (VP (VBN performed)
        (S
          (VP (VBG using)
            (NP
              (NP (DT the) (JJ improved) (JJ biotin-streptavidin-amplified) (NN detection) (NN system))
              (PRN (-LRB- -LRB-)
                (NP (NNP Vector) (NNP Laboratories) (NNP Inc.))
                (, ,)
                (NP (NNP Burlingame))
                (, ,)
                (NP (NNP CA) (, ,) (NNP USA))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (S
      (ADVP (RB Briefly))
      (, ,)
      (PP (VBG according)
        (PP (TO to)
          (NP (DT this) (NN method))))
      (, ,)
      (NP (NNS cells))
      (VP (VBD were)
        (VP (VBN incubated)
          (PP (IN with)
            (NP
              (NP
                (NP (DT the) (JJ secondary) (NN antibody))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (JJ biotinylated) (NN IgG))
                    (, ,)
                    (NP (CD 1:20) (NN dilution)))
                  (-RRB- -RRB-)))
              (PP (IN for)
                (NP (CD 20) (NN min)))))
          (PP (IN at)
            (NP (NN room) (NN temperature))))))
    (CC and)
    (S
      (ADVP (RB then))
      (, ,)
      (PP (IN after)
        (NP
          (NP (JJ several) (NNS washes))
          (PP (IN in)
            (NP (NNP PBS)))))
      (, ,)
      (NP (NNS cells))
      (VP
        (VP (VBD were)
          (VP (VBN treated)
            (PP (IN with)
              (NP
                (NP (DT the)
                  (ADJP (JJ concentrated) (JJ enzyme))
                  (NN label))
                (PRN (-LRB- -LRB-)
                  (ADJP (JJ biotin-streptavidin-peroxidase))
                  (-RRB- -RRB-))))
            (PP (IN for)
              (NP (CD 20) (NN min)))))
        (CC and)
        (PRN (, ,)
          (ADVP (RB finally))
          (, ,))
        (VP (VBN incubated)
          (PP (IN at)
            (NP (NN room) (NN temperature)))
          (PP (IN with)
            (NP (DT the) (JJ peroxidase-substrate) (NN solution)))
          (PRN (-LRB- -LRB-)
            (S
              (NP
                (NP
                  (ADJP
                    (NP (CD 0.04) (NN %))
                    (JJ 3,3-diaminobenzidine))
                  (JJ -LSB-) (JJ Sigma-Aldrich) (NNS -RSB-))
                (PP (IN in)
                  (NP (CD 50) (NNP mM) (NNP Tris-HCl) (NN buffer))))
              (VP (VBG containing)
                (NP
                  (ADJP (CD 0.3) (NN %))
                  (NN hydrogen) (NN peroxide))))
            (-RRB- -RRB-))
          (PP (IN for)
            (NP (CD 15) (NN min))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (S
        (VP (VBG rinsing)
          (PP (IN with)
            (NP (NNP PBS))))))
    (, ,)
    (NP (NNP slides))
    (VP
      (VP (VBD were)
        (VP (VBN counterstained)
          (PP (IN with)
            (NP (NN haematoxylin)))))
      (, ,)
      (VP (VBD were)
        (ADJP (JJ dried)))
      (CC and)
      (VP (VBP cover)
        (S
          (VP (VBN slipped)
            (PP (IN with)
              (NP (NNP Eukitt))))))
      (, ,)
      (CC and)
      (VP (VBD were)
        (VP (VBN examined)
          (PP (IN by)
            (NP
              (NP (JJ light) (NN microscopy))
              (CC and)
              (NP (JJ computerized) (NN image) (NN analysis)))))))
    (. .)))

(ROOT
  (S
    (NP (NNS Controls))
    (VP (VBD were)
      (VP (VBN treated)
        (ADVP (RB identically))
        (, ,)
        (PP (IN except)
          (PP (IN for)
            (S
              (VP (VBG omitting)
                (NP (DT the) (JJ primary)
                  (CC or)
                  (JJ secondary) (NNS antibodies))))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Image) (NN analysis))
    (VP (VBD was)
      (VP (VBN performed)
        (PP (IN with)
          (NP
            (NP (DT the) (NNP Leica) (NNP Q500) (NNP MC) (NNP Image) (NNP Analysis) (NNP System))
            (PRN (-LRB- -LRB-)
              (NP (NNP Leica))
              (, ,)
              (NP (NNP Cambridge))
              (, ,)
              (NP (NNP UK))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (PP (IN For)
      (NP (DT each) (NN sample)))
    (, ,)
    (S
      (NP (CD 100) (NNS cells))
      (VP (VBD were)
        (ADJP (RB randomly) (JJ analysed))))
    (CC and)
    (S
      (NP
        (NP (DT the) (NNS pixels))
        (PP (IN per)
          (NP
            (NP (NN micron) (NN square))
            (PRN (-LRB- -LRB-)
              (NP (JJ positive) (NN area))
              (-RRB- -RRB-)))))
      (VP (VBD were)
        (VP (VBN quantified)
          (PP (IN by)
            (NP (DT the) (NNP Leica) (NNP Q500) (NN software))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (JJ single) (NNS cells))
    (VP (VBD were)
      (ADVP (RB randomly))
      (VP
        (VP (VBN selected)
          (PP (IN by)
            (S
              (NP (DT the) (NNS operators))
              (VP (VBG using)
                (NP (DT the) (NN cursor))))))
        (CC and)
        (ADVP (RB then))
        (VP
          (ADVP (RB automatically))
          (VBN measured)
          (PP (IN as)
            (NP (DT the) (JJ positive) (NN area))))))
    (. .)))

(ROOT
  (S
    (NP (DT A) (JJ constant) (JJ optical) (NN threshold)
      (CC and)
      (NN filter) (NN combination))
    (VP (VBD was)
      (VP (VBN set)
        (S
          (VP (TO to)
            (VP (VB select)
              (NP (RB only) (DT the) (JJ positive) (NNS cells)))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (DT The) (NNS results))
      (VP (VBD were)
        (VP (VBN analysed)
          (PP (IN by)
            (NP
              (NP (DT the) (NN analysis))
              (PP (IN of)
                (NP
                  (NP (JJ variance) (JJ non-parametric) (NN test))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP Bonferroni) (NN test))
                    (-RRB- -RRB-)))))))))
    (, ,)
    (CC and)
    (S
      (NP (DT the) (NNS values))
      (VP (VBP are)
        (VP (VBN presented)
          (SBAR (IN as)
            (S
              (VP (VBZ means)
                (NP (JJ ±) (JJ standard) (NNS deviations))))))))
    (. .)))

(ROOT
  (S
    (NP (NNS Cells))
    (VP (VBD were)
      (VP (VBN lysed)
        (PP (IN in)
          (NP (NN buffer)))
        (S
          (VP (VBG containing)
            (NP
              (NP (CD 20) (NN mM) (NNP Tris-HCl))
              (, ,)
              (NP (CD 150) (NN mM) (NNP NaCl))
              (, ,)
              (NP (CD 1) (NN mM) (NN phenylmethylsulfonylfluoride))
              (, ,)
              (NP (CD 5) (JJ mg/ml) (NN aprotinin))
              (, ,)
              (NP
                (NP
                  (ADJP (CD 0.5) (NN %))
                  (NNP Nonidet) (NNP P-40))
                (PRN (-LRB- -LRB-)
                  (NP (NNP Sigma-Aldrich))
                  (-RRB- -RRB-))))
            (PP (IN for)
              (NP
                (NP (CD 1) (NN hour))
                (PP (IN at)
                  (NP (CD 4) (NN °) (NNP C)))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNS lysates))
    (VP (VBD were)
      (VP (VBN centrifuged)
        (PP (IN for)
          (NP
            (NP (CD 10) (NN min))
            (PP (IN at)
              (NP (CD 13,000) (NN rpm)))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNS surnatants))
    (VP (VBD were)
      (VP (VBN collected)
        (CC and)
        (VBN stored)
        (PP (IN at)
          (NP (NNP -80) (NNP °) (NNP C)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NNS samples))
      (PP (IN of)
        (NP (NNS surnatants))))
    (VP
      (VP (VBD were)
        (VP
          (ADVP (RB thereafter))
          (VBN diluted)
          (PP (IN with)
            (S
              (VP (VBG reducing)
                (NP (NN sample) (NN buffer)))))))
      (CC and)
      (VP (VBD were)
        (VP (VBN separated)
          (PP (IN by)
            (NP
              (NP (NNS electrophoresis))
              (PP (IN on)
                (NP
                  (NP (DT a)
                    (ADJP (CD 10) (NN %))
                    (NN SDS-PAGE) (NN gel))
                  (PRN (-LRB- -LRB-)
                    (NP
                      (NP (CD 20) (NN μg) (NN protein))
                      (PP (IN per)
                        (NP (NN lane)))
                      (VP (VBN loaded)))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNS proteins))
    (VP (VBD were)
      (VP (VBN transferred)
        (PP (IN onto)
          (NP
            (NP (NNP Hybond-C-nitrocellulose) (NNP membrane))
            (PRN (-LRB- -LRB-)
              (NP (NNP Amersham) (NNP Italia))
              (, ,)
              (NP (NNP Milan))
              (, ,)
              (NP (NNP Italy))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NN reaction))
    (VP (VBD was)
      (VP (VBN blocked)
        (PP (IN by)
          (NP
            (NP (NNS DPBS))
            (PP (IN with)
              (NP
                (ADJP (CD 5) (NN %))
                (ADJP (JJ non-fat) (JJ powdered))
                (NN milk)))))
        (PP (IN at)
          (NP
            (QP (CD 4) (CD °)))
          (NP
            (NP (NNP C))
            (ADVP (RB overnight))))))
    (. .)))

(ROOT
  (S
    (PP (IN For)
      (NP (JJ immunoblot) (NN analysis)))
    (, ,)
    (NP (DT the) (NNS membranes))
    (VP
      (VP (VBD were)
        (VP (VBN incubated)
          (PP (IN with)
            (NP
              (NP (DT the) (JJ different) (NNS antibodies))
              (PP (IN for)
                (NP
                  (NP (CD 1) (NN hour)
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (NNP NF-κB))
                        (, ,)
                        (NP (NNP IκB-α)))
                      (, ,)
                      (NP
                        (NP (NNP IκB-α-ser) (CD 32) (, ,) (CD respectively))
                        (: ;)
                        (NP (NNP Santa) (NNP Cruz) (NNP Biotechnology)))
                      (-RRB- -RRB-)))
                  (PRN (-LRB- -LRB-)
                    (NP (NN dilution) (CD 1:200))
                    (-RRB- -RRB-))))))
          (PP (IN in)
            (NP
              (NP (NNS DPBS))
              (PP (IN at)
                (NP
                  (NP (NN room) (NN temperature))
                  (PP (IN with)
                    (NP (JJ constant) (VBG shaking)))))))))
      (, ,)
      (CC and)
      (VP (VBD were)
        (VP (VBN washed)
          (ADVP (RB extensively))
          (PP (IN in)
            (NP
              (NP (CD 0.05) (NN %))
              (ADJP
                (NP (NNP DPBS/Tween) (CD 20) (, ,) (CD pH))
                (JJ 7.4)))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Finally))
    (, ,)
    (NP (DT the) (NNS membranes))
    (VP (VBD were)
      (VP (VBN incubated)
        (PP (IN with)
          (NP
            (NP
              (NP (JJ secondary) (JJ horseradish) (JJ peroxidase-labelled) (JJ polyclonal) (JJ anti-goat) (NN IgG) (NN antibody))
              (PRN (-LRB- -LRB-)
                (NP
                  (NP (NN SC-2020))
                  (: ;)
                  (NP (NNP Santa) (NNP Cruz) (NNP Biotechnology)))
                (-RRB- -RRB-)))
            (PRN (-LRB- -LRB-)
              (NP (NN dilution) (CD 1:5000))
              (-RRB- -RRB-))))
        (PP (IN in)
          (NP
            (NP (NNS DPBS))
            (PP (IN for)
              (NP
                (NP (CD 1) (NN hour))
                (PP (IN at)
                  (NP (NN room) (NN temperature)))))))))
    (. .)))

(ROOT
  (S
    (PP (IN After)
      (S
        (VP (VBG washing)
          (NP
            (NP (CD three) (NNS times))
            (PP (IN in)
              (NP (NNP DPBS)))))))
    (, ,)
    (NP (DT the) (NNS bands))
    (VP (VBD were)
      (VP (VBN detected)
        (S
          (VP (VBG using)
            (NP
              (NP (DT the) (JJ enhanced) (NN chemiluminescence) (NN system))
              (PRN (-LRB- -LRB-)
                (NP (NNP Amersham) (NNP Italia))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ Double-stranded) (NNS oligonucleotides))
      (VP (VBN corresponding)
        (PP (TO to)
          (NP
            (NP (DT the)
              (ADJP (JJ wild-type)
                (CC and)
                (JJ mutated))
              (JJ NF-κB) (NN consensus) (NN element))
            (PRN (-LRB- -LRB-)
              (NP (NNP Santa) (NNP Cruz) (NNP Biotechnology))
              (-RRB- -RRB-))))))
    (VP (VBD were)
      (VP (VBN used)
        (PP
          (PP (IN as)
            (NP (JJ 32P-labelled) (NNS probes)))
          (CC or)
          (PP (IN as)
            (NP
              (NP (JJ unlabelled) (NNS competitors))
              (PRN (-LRB- -LRB-)
                (NP
                  (QP (CD 100) (NNS times)))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNS assays))
    (VP (VBD were)
      (VP (VBN performed)
        (PP (IN in)
          (NP
            (NP
              (NP (DT a) (JJ final) (NN volume))
              (PP (IN of)
                (NP
                  (NP (CD 20) (NN μl))
                  (VP (VBG containing)
                    (NP
                      (NP (CD 10) (NN mM) (NNP Tris-HCl))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (QP (CD pH) (CD 7.5)))
                        (-RRB- -RRB-)))))))
            (, ,)
            (NP
              (QP (CD 50) (CD mM))
              (NNP NaCl)
              (PRN (, ,)
                (NP (CD 1))
                (ADJP (RB mM) (JJ dithiothreitol))
                (, ,)
                (NP (CD 1))
                (ADJP (RB mM) (JJ ethylenediamine)))
              (JJ tetraacetic) (NN acid))
            (CC and)
            (NP
              (ADJP (CD 10) (NN %))
              (NN glycerol))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Briefly))
    (, ,)
    (NP
      (NP (CD 7) (NN μg) (NN cell) (JJ nuclear) (NNS extracts))
      (, ,)
      (VP (VBN unstimulated)
        (CC or)
        (VBN stimulated)
        (PP (IN with)
          (NP (NN testosterone)
            (CC and)
            (NN E2)))
        (SBAR (IN as)
          (S
            (ADVP (RB previously))
            (VP (VBD described)))))
      (, ,))
    (VP (VBD were)
      (VP (VBN pre-incubated)
        (PP (IN with)
          (NP
            (NP
              (NP (CD 4) (NN μg) (NN poly))
              (PRN (-LRB- -LRB-)
                (ADJP (JJ dI-dC))
                (-RRB- -RRB-)))
            (PRN (-LRB- -LRB-)
              (NP (NNP Pharmacia))
              (, ,)
              (NP (NNP Milan))
              (, ,)
              (NP (NNP Italy))
              (-RRB- -RRB-))))
        (PP (IN as)
          (NP (DT a) (JJ non-specific) (NN competitor)))
        (, ,)
        (PP (IN for)
          (NP
            (NP (CD 10) (NN min))
            (PP (IN at)
              (NP (NN room) (NN temperature)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (JJ End-labelled) (NNS oligonucleotides))
      (PRN (-LRB- -LRB-)
        (NP
          (NP (CD 10) (NN fmol))
          (, ,)
          (NP (RB about) (CD 30,000) (NN cpm)))
        (-RRB- -RRB-)))
    (VP
      (VP (VBD were) (RB then)
        (VP (VBN added)
          (PP (TO to)
            (NP (DT each) (NN mixture)))
          (PP (TO to)
            (NP
              (NP (DT a) (JJ final) (NN volume))
              (PP (IN of)
                (NP (CD 20) (NN μl)))))))
      (CC and)
      (VP (VBD were)
        (VP (VBN incubated)
          (PP (IN for)
            (NP (DT an) (JJ additional) (CD 20) (NNS min))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (JJ bound/retarded) (NNS complexes))
    (VP
      (VP (VBD were)
        (VP (VBN separated)
          (PP (IN from)
            (NP (DT the) (JJ free) (NN probe)))
          (PP (IN by)
            (NP
              (NP (NNS electrophoresis))
              (PP (IN on)
                (NP
                  (ADJP (CD 5) (NN %))
                  (NN polyacrylamide) (NNS gels)))))))
      (CC and)
      (VP (VBD were)
        (VP (VBN visualized)
          (PP (IN by)
            (NP
              (NP (NN autoradiography))
              (PP (IN of)
                (NP (DT the) (JJ dried) (NNS gels))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT A) (NN lane))
      (PP (IN without)
        (NP (JJ nuclear) (NNS extract))))
    (VP (VBD was)
      (ADVP (RB also))
      (VP (VBN included)
        (PP (IN as)
          (NP (DT the) (JJ negative) (NN control)))))
    (. .)))

(ROOT
  (S
    (NP (NN Competition) (NNS experiments))
    (VP (VBD were)
      (VP
        (VP (VBN performed)
          (PP (IN in)
            (NP
              (NP (DT the) (NN presence))
              (PP (IN of)
                (NP
                  (NP (DT a) (JJ 100-fold) (NN molar) (NN excess))
                  (PP (IN of)
                    (NP (JJ unlabelled) (NN wall-type))))))))
        (CC or)
        (VP (VBN mutated)
          (NP
            (NP (JJ NF-κB) (NN oligonucleotide))
            (, ,)
            (VP (VBN added)
              (PP (TO to)
                (NP (DT the) (JJ pre-incubation) (NN step))))))))
    (. .)))

(ROOT
  (S
    (PP (IN For)
      (NP (DT the) (JJ super) (NN shift) (NN assay)))
    (, ,)
    (NP
      (NP (CD 2) (NN μl) (NN anti-p65) (, ,) (NN c-rel)
        (CC and)
        (JJ p50) (JJ NF-κB) (NN subunit) (NNS antibodies))
      (PRN (-LRB- -LRB-)
        (NP (NNP Santa) (NNP Cruz) (NNP Biotechnology))
        (-RRB- -RRB-)))
    (VP (VBD were)
      (VP (VBN included)
        (PP (IN in)
          (NP (DT the) (JJ pre-incubation) (NN mixture)))
        (PP (RB prior)
          (PP (TO to)
            (NP
              (NP (DT the) (NN addition))
              (PP (IN of)
                (NP (DT the) (NN probe))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT A) (NN lane))
      (VP (VBG containing)
        (NP (JJ pre-immune) (NN serum))))
    (VP (VBD was)
      (ADVP (RB always))
      (VP (VBN included)
        (PP (IN as)
          (NP (DT the) (NN control)))))
    (. .)))

(ROOT
  (S
    (NP (NNS Results))
    (SBAR (IN As)
      (S
        (ADVP (RB already))
        (VP (VBD stated) (, ,)
          (S
            (NP (JJ hormonal) (NNS signals))
            (VP (VB regulate)
              (NP
                (NP (DT the) (NN amount))
                (PP (IN of)
                  (NP (DT the)
                    (UCP
                      (NP (JJ cell-cycle) (NN control) (NNS proteins))
                      (CC and)
                      (PP (IN of)
                        (NP (DT the) (NN transcription))))
                    (NNS factors)))))))))
    (VP (VBZ -LSB-)
      (NP (CD 26) (NNS -RSB-)))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT the) (JJ present) (NN study)))
    (, ,)
    (PP (IN after)
      (NP (CD 168) (NNS hours)))
    (NP (PRP we))
    (VP (VBD observed)
      (NP
        (NP (DT a) (JJ significant) (NN growth) (NN inhibition))
        (PP (IN of)
          (NP
            (NP (DT the) (JJ human) (JJ monocytic) (NN cell) (NN line))
            (VP
              (VP (VBN activated)
                (PP (IN with)
                  (NP (NNP IFN-γ))))
              (CC and)
              (VP (VBN treated)
                (PP (IN with)
                  (NP
                    (NP (NN testosterone))
                    (, ,)
                    (SBAR
                      (WHADVP (WRB when))
                      (S
                        (S
                          (VP (VBN compared)
                            (PP (IN with)
                              (NP (DT the) (JJ other) (NNS conditions)))))
                        (VP (VBD studied))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN At)
      (NP (CD 168) (NNS hours)))
    (NP (DT the) (NN cell) (NN growth))
    (VP (VBD was)
      (VP (VBN reduced)
        (PP
          (PP (IN by)
            (NP
              (NP (CD 14.8) (NN %))
              (PP (IN versus)
                (NP (JJ untreated) (NNS controls)))))
          (CC and)
          (PP (IN by)
            (NP
              (NP (CD 12.7) (NN %))
              (PP (IN versus)
                (NP (NN E2-treated) (NNS cells))))))))
    (. .)))

(ROOT
  (S
    (NP (DT These) (NNS data))
    (VP (VBD were)
      (VP
        (VP (VBN obtained)
          (PP (IN with)
            (NP (DT the) (JJ methyl-tetrazolium) (NN salt) (NN test))))
        (CC and)
        (VP (VBN confirmed)
          (PP (IN with)
            (NP
              (NP (DT the) (JJ trypan) (JJ blue) (NN exclusion) (NN assay))
              (PRN (-LRB- -LRB-)
                (NP
                  (QP (CD Fig.) (CD 1)))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (JJ bromodeoxyuridine/propidium) (JJ iodide) (NN incorporation) (NN test))
    (VP (VBD showed)
      (NP
        (NP (JJ similar) (NNS results))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (NNS data))
            (VP (RB not) (VBN shown)))
          (-RRB- -RRB-))))
    (. .)))

(ROOT
  (S
    (NP (JJ Further) (JJ interesting) (NNS data))
    (VP (VBD were)
      (VP (VBN related)
        (PP (TO to)
          (NP
            (NP (DT the) (NN modulation))
            (PP (IN of)
              (NP (DT the) (NNP PCNA) (NN expression)))))
        (, ,)
        (PP (IN as)
          (NP
            (NP (DT a) (NN marker))
            (PP (IN for)
              (NP (VBG proliferating) (NNS cells)))))))
    (. .)))

(ROOT
  (S
    (S
      (NP (DT This) (NN marker))
      (VP (VBD was)
        (VP (VBN analysed)
          (PP (IN by)
            (NP (NN immunocytochemistry))))))
    (CC and)
    (S
      (NP (DT the) (NNS data))
      (VP (VBD were)
        (VP (VBN confirmed)
          (PP (IN by)
            (NP (JJ western) (NN blot) (NN analysis))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT the) (JJ testosterone-treated) (NNS cells)))
    (, ,)
    (NP
      (NP (DT the) (NN expression))
      (PP (IN of)
        (NP
          (NP (DT the) (NNP PCNA))
          (PP (IN at)
            (NP (DT the) (JJ immunocytochemistry) (NN analysis))))))
    (VP
      (VP (VBD was)
        (VP (VBN found)
          (S
            (VP (VBN decreased)
              (PP (IN by)
                (NP (CD 24) (NN %)))))
          (SBAR
            (WHADVP (WRB when))
            (S
              (VP (VBN compared)
                (PP (IN with)
                  (NP (JJ untreated) (NNS cells))))))))
      (, ,)
      (CC and)
      (VP (VBD was)
        (VP (VBN decreased)
          (PP (IN by)
            (NP (CD 40) (NN %)))
          (SBAR
            (WHADVP (WRB when))
            (S
              (VP (VBN compared)
                (PP (IN with)
                  (NP (NN E2-treated) (NNS cells)))
                (PRN (-LRB- -LRB-)
                  (NP
                    (NP (NNP Fig.) (NNPS 2a))
                    (: --)
                    (NP (SYM d)))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Interestingly))
    (, ,)
    (NP (DT the) (JJ testosterone-treated) (NNS cells))
    (VP (VBD showed)
      (S
        (VP (VBG staining)
          (ADJP (RB positivity) (JJ localized))
          (PP (IN in)
            (NP (DT the) (NN cell) (NN cytoplasm)))))
      (, ,)
      (SBAR (IN whereas)
        (S
          (PP (IN in)
            (NP (DT the)
              (ADJP (JJ untreated)
                (CC and)
                (JJ E2-treated))
              (NNS cells)))
          (NP (DT the) (NNP PCNA) (NN expression))
          (VP (VBD was)
            (VP (VBN found)
              (ADVP (RB predominantly))
              (PP (IN in)
                (NP (DT the) (NN nucleus))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (DT the) (JJ present) (NN study)))
    (NP
      (NP (DT the) (JJ inhibitory) (NN role))
      (PP (IN of)
        (NP
          (NP
            (NP (NNP E2))
            (PP (IN on)
              (NP (NNS apoptosis))))
          (, ,)
          (CONJP (RB as) (RB well) (IN as))
          (NP
            (NP (DT the) (JJ pro-apoptotic) (NNS effects))
            (VP (VBN exerted)
              (PP (IN by)
                (NP (NN testosterone)))
              (PP (IN in)
                (NP
                  (NP (JJ long-term) (NN treatment))
                  (PP (IN of)
                    (NP (NN THP-1) (NNS cells)))))))))
      (, ,))
    (VP (VBD were)
      (VP (VBN investigated)))
    (. .)))

(ROOT
  (S
    (NP (DT The) (JJ annexin) (JJ V-propidium) (NN iodide) (NN analysis))
    (VP (VBD showed)
      (NP
        (NP (DT a) (JJ significant) (NN increase))
        (PP (IN of)
          (NP (JJ early)
            (CC and)
            (JJ late) (NNS apoptosis))))
      (PP (IN in)
        (NP (JJ testosterone-treated) (NNS cells)))
      (SBAR
        (WHADVP (WRB when))
        (S
          (VP (VBN compared)
            (PP (IN with)
              (NP (JJ other) (NNS conditions)))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (DT the) (NN absence))
        (PP (IN of)
          (NP (NN staurosporine)))))
    (, ,)
    (NP (DT the) (NNS apoptosis))
    (VP (VBD was)
      (VP (VBN found)
        (S
          (VP (VBN increased)
            (PP (IN in)
              (NP
                (NP (JJ testosterone-treated) (NNS cells))
                (PRN (-LRB- -LRB-)
                  (NP (CD 9.9) (NN %))
                  (-RRB- -RRB-))))))
        (SBAR
          (WHADVP (WRB when))
          (S
            (VP (VBN compared)
              (PP
                (PP (IN with)
                  (NP
                    (NP (NN control) (NN untreated) (NNS cells))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 2.7) (NN %))
                      (-RRB- -RRB-))))
                (CC and)
                (PP (IN with)
                  (NP
                    (NP (NN E2-treated) (NNS cells))
                    (PRN (-LRB- -LRB-)
                      (NP (CD 3.8) (NN %))
                      (-RRB- -RRB-))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (DT the) (NN presence))
        (PP (IN of)
          (NP (NN staurosporine)))))
    (, ,)
    (NP (DT the) (JJ apoptotic) (NNS cells))
    (VP (VBD were)
      (VP (VBN increased)
        (PP (IN in)
          (NP (DT all) (NNS conditions)))))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP
        (NP (JJ testosterone-treated) (NNS cells))
        (PRN (-LRB- -LRB-)
          (NP (CD 24.8) (NN %))
          (-RRB- -RRB-))))
    (NP (DT the) (NNS apoptosis))
    (VP (VBD was)
      (VP (VBN found)
        (S
          (VP (VBN increased)
            (SBAR
              (WHADVP (WRB when))
              (S
                (VP (VBN compared)
                  (PP (IN with)
                    (NP
                      (NP
                        (ADJP (JJ untreated))
                        (NNS cells))
                      (PRN (-LRB- -LRB-)
                        (NP (CD 19.4) (NN %))
                        (-RRB- -RRB-)))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN On)
      (NP (DT the)
        (ADJP
          (ADJP (JJ contrary) (, ,)
            (PP (IN in)
              (NP (DT the) (NN E2-treated))))
          (PRN (-LRB- -LRB-)
            (NP (CD 15) (NN %))
            (-RRB- -RRB-)))
        (NNS cells)))
    (NP (DT the) (NNS apoptosis))
    (VP (VBD was)
      (VP (VBN decreased)
        (PP (FW versus)
          (NP
            (NP
              (NP (NNS controls))
              (PRN (-LRB- -LRB-)
                (NP (CD 19.4) (NN %))
                (-RRB- -RRB-)))
            (PRN (-LRB- -LRB-)
              (NP (NNP Fig.) (CD 3a))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (DT These) (NNS data))
    (VP (VBD were)
      (VP (VBN confirmed)
        (PP (IN by)
          (NP
            (NP (NN flow) (NN analysis) (NN cytometry) (NN scatter) (NN analysis))
            (PRN (-LRB- -LRB-)
              (NP
                (NP (NNP Fig.) (NNPS 3b))
                (, ,)
                (NP (SYM c)))
              (-RRB- -RRB-))))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (JJ immunocytochemistry) (NN analysis))
    (VP (VBD showed)
      (NP
        (NP (DT a) (JJ significant) (NN increase))
        (PP (IN of)
          (NP
            (NP (DT the) (JJ PARP-cleaved) (NN form))
            (PP (IN in)
              (NP
                (NP (JJ testosterone-treated) (NNS cells))
                (PP (VBN compared)
                  (PP (IN with)
                    (NP (JJ other) (NNS conditions)))))))))
      (, ,)
      (S
        (VP (VBG suggesting)
          (NP
            (NP (DT an) (NN increase))
            (PP (IN of)
              (NP (JJ pro-apoptotic) (NNS events)))))))
    (. .)))

(ROOT
  (S
    (PP (IN On)
      (NP (DT the) (NN contrary)))
    (, ,)
    (NP (DT the) (JJ PARP-cleaved) (NN staining))
    (VP (VBD showed)
      (NP
        (NP (DT a) (NN decrease))
        (PRN (-LRB- -LRB-)
          (NP
            (NP (CD 19) (NN %))
            (CC versus)
            (NP (JJ untreated) (NNS controls)))
          (-RRB- -RRB-)))
      (PP (IN in)
        (NP (NN E2-treated) (NNS cells)))
      (, ,)
      (S
        (VP (VBG suggesting)
          (NP
            (NP (DT a) (NN trend))
            (PP (IN of)
              (NP (NNS oestrogens))))
          (PP (IN in)
            (S
              (VP (VBG protecting)
                (NP (NNS cells))
                (PP (IN from)
                  (NP
                    (NP (DT the) (JJ apoptotic) (NNS stimuli))
                    (PRN (-LRB- -LRB-)
                      (NP
                        (NP (NNP Fig.) (NNPS 4a))
                        (: --)
                        (NP (NNP e)))
                      (-RRB- -RRB-))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT These) (NNS data))
    (VP (VBD were)
      (VP (VBN confirmed)
        (PP (IN with)
          (NP (JJ western) (NN blot) (NN analysis)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (JJ defined) (NN mechanism))
      (PP (IN of)
        (NP (JJ NF-κB) (NN activation))))
    (VP (VBZ includes)
      (NP
        (NP (DT the) (JJ site-specific) (NN phosphorylation)
          (CC and)
          (JJ subsequent) (NN degradation))
        (PP (IN of)
          (NP
            (NP (DT the)
              (ADJP (RB inhibitory) (JJ IκB-α))
              (NN factor))
            (, ,)
            (SBAR
              (WHNP (WDT which))
              (S
                (ADVP (RB usually))
                (VP (VBZ retains)
                  (NP
                    (NP (DT the) (JJ NF-κB) (NNS factors))
                    (VP (VBN inactivated)
                      (PP (IN in)
                        (NP (JJ cytosol) (NNP -LSB-) (CD 27) (NNS -RSB-))))))))))))
    (. .)))

(ROOT
  (S
    (NP (PRP We))
    (ADVP (RB therefore))
    (VP (VBD performed)
      (NP (JJ western) (NN blot) (NN analysis))
      (S
        (VP (TO to)
          (VP (VB detect)
            (NP
              (NP
                (NP
                  (NP (DT the) (NN expression))
                  (PP (IN of)
                    (NP (NNP NF-κB))))
                (PRN (-LRB- -LRB-)
                  (NP (CD p65))
                  (-RRB- -RRB-))
                (, ,)
                (NP (NNP IκB-α))
                (CC and)
                (NP (DT the) (JJ IκB-α) (JJ phosphorylated) (NN form)))
              (PRN (-LRB- -LRB-)
                (NP
                  (QP (CD IκB-α-ser) (CD 32)))
                (-RRB- -RRB-)))
            (PP (IN in)
              (NP
                (NP (NN THP-1) (NNS cells))
                (VP (VBN treated)
                  (PP (IN with)
                    (NP (DT the) (JJ different) (NN hormone) (NNS combinations))))))))))
    (. .)))

(ROOT
  (S
    (SBAR (IN As)
      (S
        (S
          (VP (VBN shown)
            (PP (IN in)
              (NP
                (NP (JJ western) (NN blot) (NN analysis))
                (PRN (-LRB- -LRB-)
                  (NP
                    (QP (CD Fig.) (CD 5)))
                  (-RRB- -RRB-))))
            (NP
              (NP
                (NP
                  (NP (DT a) (VBN decreased) (NN expression))
                  (PP (IN of)
                    (NP (NNP NF-κB))))
                (PRN (-LRB- -LRB-)
                  (NP (CD p65))
                  (-RRB- -RRB-)))
              (CC and)
              (NP
                (NP (DT an) (VBN increased) (NN content))
                (PP (IN of)
                  (NP (NNP IκB-α)))
                (PP (IN with)
                  (NP (DT a) (JJ concomitant) (NN decrease)))
                (PP (IN of)
                  (NP (DT the) (JJ IκB-α) (JJ phosphorylated) (NN form)))))))
        (VP (VBD was)
          (VP (VBN observed)
            (PP (IN in)
              (NP (JJ testosterone-treated) (NNS cells)))
            (SBAR
              (WHADVP (WRB when))
              (S
                (VP (VBN compared)
                  (PP
                    (PP (IN with)
                      (NP (JJ untreated) (NNS controls)))
                    (CC and)
                    (PP (IN with)
                      (NP (NN E2-treated) (NN THP-1) (NNS cells)))))))))))
    (: ;)
    (S
      (NP
        (NP (DT the) (NNS differences))
        (PP (IN between)
          (NP
            (NP (NNS conditions))
            (VP (VBN observed)
              (PP (IN with)
                (NP (JJ staurosporine) (NN treatment)))))))
      (VP (VBD were)
        (ADJP (JJ similar))))
    (CC but)
    (S
      (NP (DT the) (NN expression))
      (VP (VBD was)
        (ADJP (JJR lower))))
    (. .)))

(ROOT
  (S
    (S
      (NP
        (NP (DT The)
          (ADJP (JJ observed))
          (NNS differences))
        (PP (IN between)
          (NP
            (ADJP (JJ E2-treated)
              (CC and)
              (JJ testosterone-treated))
            (NN THP-1) (NNS cells))))
      (VP (VBD were)
        (VP (VBN confirmed)
          (PP (IN by)
            (NP (JJ immunocytochemistry) (NN staining)
              (CC and)
              (NN image) (NN analysis))))))
    (: ;)
    (S
      (NP (JJ similar) (NNS data))
      (VP (VBD were)
        (VP (VBN observed)
          (PP (IN with)
            (NP
              (NP (JJ staurosporine) (NN treatment))
              (PRN (-LRB- -LRB-)
                (NP
                  (QP (CD Table) (CD 1)))
                (-RRB- -RRB-)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (JJ concomitant) (JJ electrophoretic) (JJ mobility) (NN shift) (NN assay) (NN analysis))
      (PP (IN for)
        (NP
          (NP (DT the) (NN evaluation))
          (PP (IN of)
            (NP (DT the) (NNP NF-κB) (NNP DNA) (NNP binding))))))
    (VP (VBD confirmed)
      (NP (DT an) (VBN increased) (NN binding))
      (PP (IN in)
        (NP (NN E2-treated) (NNS cells)))
      (, ,)
      (SBAR
        (WHADVP (WRB when))
        (S
          (VP (VBN compared)
            (PP (IN with)
              (NP (JJ other) (NNS conditions)))
            (PP (IN with)
              (CC or)
              (IN without)
              (NP (NN staurosporine)))
            (, ,)
            (SBAR (IN as)
              (S
                (VP (VBN shown)
                  (PP (IN in)
                    (NP (NNP Fig.) (CD 6a))))))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Finally))
    (, ,)
    (NP
      (NP (DT the) (NN gel) (NN shift) (NN assay))
      (PP (IN of)
        (NP
          (NP (JJ nuclear) (NN protein) (NNS extracts))
          (PP (IN from)
            (NP (NN E2-treated) (NNS cells))))))
    (ADVP (RB again))
    (VP (VBD showed)
      (NP
        (NP (DT an) (NN increase))
        (PP (IN of)
          (NP
            (NP (DT the) (JJ p65) (JJ subunit) (NN DNA) (VBG binding))
            (PRN (-LRB- -LRB-)
              (NP (NNP Fig.) (CD 6b))
              (-RRB- -RRB-)))))
      (SBAR
        (WHADVP (WRB when))
        (S
          (VP (VBN compared)
            (PP (IN with)
              (NP (JJ other) (NNS conditions)))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Similar) (NNS results))
    (VP (VBD were)
      (VP (VBN obtained)
        (PP (IN during)
          (NP (JJ staurosporine) (NN treatment)))))
    (. .)))

(ROOT
  (S
    (NP (NNP Discussion) (NNP Monocytes/macrophages))
    (VP (VBP contribute)
      (PP (TO to)
        (NP (DT the) (JJ autoimmune) (NN process)))
      (, ,)
      (S
        (VP
          (ADVP (RB mainly))
          (VBG acting)
          (PP (IN as)
            (NP
              (NP (JJ antigen-processing/presenting) (NNS cells)
                (CC and)
                (NNS sources))
              (PP (IN of)
                (NP (JJ inflammatory) (NNS cytokines)))))
          (, ,)
          (ADVP (RB particularly))
          (PP (IN at)
            (NP
              (NP (DT the) (NN level))
              (PP (IN of)
                (NP (DT the) (JJ synovial) (NN tissue)))))
          (PP (IN in)
            (NP (NNP RA) (NNP -LSB-) (CD 28) (NNS -RSB-))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Moreover))
    (, ,)
    (NP (NN sex) (NNS hormones))
    (VP (MD can)
      (VP (VB exert)
        (NP
          (NP (JJ local) (NNS actions))
          (PRN (-LRB- -LRB-)
            (NP (NN paracrine))
            (-RRB- -RRB-)))
        (PP (IN in)
          (NP
            (NP (DT the) (NNS tissues))
            (SBAR
              (WHPP (IN in)
                (WHNP (WDT which)))
              (S
                (NP (PRP they))
                (VP (VBP are)
                  (VP (VBN formed)))))))
        (, ,)
        (PP (VBG including)
          (NP
            (NP (DT the) (JJ synovial) (NN tissue))
            (VP (VBG -LSB-)
              (NP (CD 29,30) (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Activated) (NN THP-1) (NNS cells))
    (VP (VB differentiate)
      (PP (IN into)
        (NP
          (NP (NNS macrophages))
          (PP (IN for)
            (NP (JJ long-term) (NNS cultures))))))
    (. .)))

(ROOT
  (S
    (PP (IN On)
      (NP (DT the) (NN contrary)))
    (, ,)
    (NP (JJ synovial) (NNS macrophages))
    (VP (VBP are)
      (VP (VBN characterized)
        (PP (IN by)
          (NP (DT a) (JJ short) (NN life)))
        (PP (IN during)
          (NP
            (ADJP (IN in) (NN vitro))
            (NN culture)))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (JJ present) (NN study))
    (VP (VBZ shows)
      (NP (JJ opposite) (NNS effects))
      (PP (IN by)
        (NP
          (NP (NN sex) (NNS hormones))
          (PP (IN on)
            (NP
              (NP (NNS cultures))
              (PP (IN of)
                (NP
                  (NP
                    (NP (VBN activated) (NN monocytic/macrophage) (NNS cells))
                    (PRN (-LRB- -LRB-)
                      (NP (NN THP-1) (NNS cells))
                      (-RRB- -RRB-)))
                  (PP (VBG concerning)
                    (NP
                      (NP (PRP$ their) (JJ modulatory) (NNS effects))
                      (PP (IN on)
                        (NP (NN cell) (NN proliferation) (NN and/or) (NNS apoptosis))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (VBG signalling) (NNS pathways))
      (VP (VBG modulating)
        (SBAR
          (S
            (NP (DT the) (JJ pro-inflammatory)
              (CC and)
              (JJ anti-inflammatory) (NNS mechanisms))
            (VP (VBP seem)
              (S
                (VP (TO to)
                  (VP (VB involve)
                    (NP
                      (NP (JJ steroidal) (NN hormone) (NN receptor) (NN activation))
                      (CC and)
                      (NP (DT the) (JJ NF-κB) (JJ complex) (NNS factors)))))))))))
    (, ,)
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (NP (NNS oestrogens))
    (VP (MD may)
      (ADVP (RB differently))
      (VP (VB regulate)
        (NP (JJ NF-κB) (NN activation))
        (PP (VBG depending)
          (PP (IN on)
            (NP
              (NP (DT the) (NN cell) (NN type))
              (VP (VBN tested)
                (NP
                  (QP (CD -LSB-) (CD 14,31))
                  (NNS -RSB-))))))))
    (. .)))

(ROOT
  (S
    (NP (NNP E2))
    (VP
      (VP
        (ADVP (RB therefore))
        (VBD increased)
        (NP
          (NP (DT the) (NN expression))
          (PP (IN of)
            (NP
              (NP (NNS markers))
              (PP (IN of)
                (NP (NN cell) (NN growth)
                  (CC and)
                  (NN proliferation))))))
        (, ,)
        (SBAR (IN whereas)
          (S
            (NP (NN testosterone))
            (VP (VBN induced)
              (NP
                (NP (DT an) (NN increase))
                (PP (IN of)
                  (NP (DT the) (JJ PARP-cleaved) (NN expression))))
              (, ,)
              (S
                (VP (VBG indicating)
                  (NP (NN DNA) (NN damage))))))))
      (CC and)
      (VP (VBZ apoptosis)))
    (. .)))

(ROOT
  (S
    (PP (IN In)
      (NP (NN addition)))
    (, ,)
    (S
      (VP (TO to)
        (VP (VB support)
          (NP
            (NP (DT the) (JJ proliferative) (NN role))
            (VP (VBN exerted)
              (PP (IN by)
                (NP (NNP E2))))))))
    (, ,)
    (NP
      (NP (DT the) (NN THP-1) (NNS cells) (NN pre-treated))
      (PP (IN with)
        (NP (DT the) (NNS oestrogens))))
    (VP (VBD showed)
      (NP
        (NP (DT a) (NN decrease))
        (PP (IN of)
          (NP (JJ staurosporine-induced) (NNS apoptosis))))
      (SBAR
        (WHADVP (WRB when))
        (S
          (VP (VBN compared)
            (PP (IN with)
              (NP
                (ADJP (JJ testosterone-treated)
                  (CC and)
                  (JJ untreated))
                (NNS cells)))))))
    (. .)))

(ROOT
  (S
    (ADVP (RB Furthermore))
    (, ,)
    (NP
      (NP (DT the) (VBN increased) (JJ NF-κB) (JJ p65) (NN expression))
      (CC and)
      (NP
        (NP (DT the)
          (ADJP (JJ evident))
          (NN NF-κB))
        (ADJP (JJ binding)
          (PP (TO to)
            (NP
              (NP (NNP DNA))
              (PP (IN in)
                (NP (NN E2-treated) (NNS cells))))))))
    (PRN (, ,)
      (SBAR
        (WHADVP (WRB when))
        (S
          (VP (VBN compared)
            (PP
              (PP (IN with)
                (NP (JJ untreated) (NNS cells)))
              (CC or)
              (PP (IN with)
                (NP
                  (NP (JJ testosterone-treated) (NNS cells))
                  (, ,)
                  (CONJP (RB as) (RB well) (IN as))
                  (NP
                    (NP (DT the) (VBN increased) (NNS levels))
                    (PP (IN of)
                      (NP (DT the) (JJ IκB-α) (JJ phosphorylated) (NN form))))))))))
      (, ,))
    (VP (VBZ seems)
      (S
        (VP (TO to)
          (VP (VB support)
            (NP
              (NP (DT the) (JJ major) (JJ enhancing) (NN role))
              (VP (VBN exerted)
                (PP (IN by)
                  (NP
                    (NP (NNS oestrogens))
                    (PP (IN on)
                      (NP (DT the) (JJ immune/inflammatory) (NN response)))))
                (PP (IN by)
                  (S
                    (VP (VBG activating)
                      (NP (DT the) (JJ NF-κB) (NN complex)))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN On)
      (NP (DT the) (NN contrary)))
    (, ,)
    (NP
      (NP (DT the)
        (ADJP (JJ observed) (JJ positive))
        (NN upregulation))
      (PP (IN of)
        (NP
          (NP (NNP IκB-α))
          (VP (VBN exerted)
            (PP (IN by)
              (NP (JJ testosterone) (NN treatment)))))))
    (VP
      (VP
        (ADVP (RB presumably))
        (VBZ dampens)
        (NP
          (NP (DT the) (JJ pro-inflammatory) (NNS effects))
          (VP (VBN mediated)
            (PP (IN by)
              (NP (DT the) (JJ NF-κB) (NN activation))))))
      (, ,)
      (CC and)
      (VP
        (ADVP (RB therefore))
        (MD might)
        (VP (VB represent)
          (NP (DT a) (JJ further) (NN mechanism))
          (PP (IN by)
            (SBAR
              (WHNP (WDT which))
              (S
                (VP (VBZ androgens)
                  (NP (JJ exert) (JJ anti-inflammatory) (NNS effects)))))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Recent) (NNS studies))
    (VP (VBP support)
      (NP (DT these) (NNS results))
      (, ,)
      (S
        (VP (VBG showing)
          (SBAR (IN that)
            (S
              (NP (NNP E2))
              (VP (VBZ inhibits)
                (NP
                  (NP (NNS apoptosis))
                  (PP (IN in)
                    (NP
                      (NP (JJ different) (NN cell) (NNS types))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (NP (JJ cardiac) (NNS myocytes))
                          (CC and)
                          (NP (NNS others)))
                        (-RRB- -RRB-))))))))))
      (SBAR (IN whereas)
        (S
          (NP (NNS androgens))
          (VP (VBP have)
            (VP (VBN been)
              (VP (VBN found)
                (S
                  (VP (TO to)
                    (VP (VB induce)
                      (NP
                        (NP (NNS apoptosis))
                        (VP (VBG -LSB-)
                          (NP (CD 32,33) (NNS -RSB-)))))))))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (VBN increased) (NNS concentrations))
      (PP (IN of)
        (NP
          (NP (NNS oestrogens))
          (PRN (-LRB- -LRB-)
            (CC and)
            (ADJP (JJ low) (JJ androgens))
            (-RRB- -RRB-))
          (VP
            (ADVP (RB recently))
            (VBN described)
            (PP (IN at)
              (NP
                (NP (DT the) (NN level))
                (PP (IN of)
                  (NP
                    (NP (DT the) (JJ synovial) (NN fluid))
                    (PP (IN of)
                      (NP
                        (NP (NNP RA) (NNS patients))
                        (PP (IN of)
                          (NP (DT both) (NNS sexes)))))))))
            (S
              (VP (VBG -LSB-)
                (NP (CD 29) (NNS -RSB-))))))))
    (VP (VBP seem)
      (S
        (VP (TO to)
          (VP (VB support)
            (NP (PRP$ their) (JJ possible) (NN modulator) (NNS roles))
            (PP (IN on)
              (NP
                (NP (JJ synovial) (NN tissue) (NN hyperplasia))
                (CC and)
                (NP (JJ chronic) (JJ synovial) (NN cell) (NN activation))))
            (, ,)
            (PP (IN by)
              (S
                (VP (VBG considering)
                  (NP (DT the) (JJ oestrogenic) (NNS effects))
                  (PP (IN on)
                    (NP (NN cell) (NN proliferation)
                      (CC and)
                      (NNS apoptosis))))))))))
    (. .)))

(ROOT
  (S
    (NP (DT These) (NNS observations))
    (VP (VBP have)
      (VP (VBN been)
        (VP
          (ADVP (RB recently))
          (VBN obtained)
          (ADVP (RB also))
          (PP (IN in)
            (NP (JJ human) (NN breast) (NN cancer) (NNS cells)))
          (S
            (VP (VBG -LSB-)
              (NP (CD 34) (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (S
      (VP (TO To)
        (VP (VB explain)
          (NP
            (NP (VBN increased) (NN oestrogen) (NNS concentrations))
            (PP (IN in)
              (NP (NNP RA) (NN synovial) (NNS fluids)))))))
    (, ,)
    (NP
      (NP (DT the) (JJ pro-inflammatory) (NNS cytokines))
      (PRN (-LRB- -LRB-)
        (NP (JJ tumour) (NN necrosis) (NN factor) (NN alpha))
        (, ,)
        (NP (NNP IL-1β))
        (, ,)
        (NP (NNP IL-6))
        (-RRB- -RRB-)))
    (VP (VBP have)
      (VP (VBN been)
        (VP (VBN found)
          (S
            (VP (TO to)
              (VP (VB accelerate)
                (NP
                  (NP (DT the) (JJ metabolic) (NN conversion))
                  (PP (IN of)
                    (NP
                      (NP (NNS oestrogens))
                      (PP (IN from)
                        (NP (NNS androgens))))))
                (PP (IN by)
                  (S
                    (VP (VBG inducing)
                      (NP (DT the) (JJ synovial) (NN tissue) (NNS aromatases))
                      (S
                        (VP (VBG -LSB-)
                          (NP (CD 35-37) (NNS -RSB-)))))))))))))
    (. .)))

(ROOT
  (S
    (PP (IN As)
      (NP (DT a) (NN consequence)))
    (, ,)
    (NP (RB locally) (JJ increased) (NN oestrogen) (NNS levels))
    (VP (MD might)
      (VP (VB exert)
        (NP (VBG activating) (NNS effects))
        (PP (IN on)
          (NP (JJ synovial) (NN cell) (NN proliferation)))
        (, ,)
        (PP (VBG including)
          (NP
            (NP (NNS macrophages)
              (CC and)
              (NNS fibroblasts))
            (VP (VBG -LSB-)
              (NP (CD 38) (NNS -RSB-)))))))
    (. .)))

(ROOT
  (S
    (NP (NNP Conclusion))
    (PP (IN In)
      (NP (DT the) (JJ present) (NN study)))
    (NP
      (NP (DT the) (NNS concentrations))
      (PP (IN for)
        (NP (NN E2)
          (CC and)
          (NN testosterone)))
      (VP (VBN tested)))
    (VP (VBP seem)
      (S
        (VP (TO to)
          (VP (VB modulate)
            (NP
              (NP (DT the) (NN activity))
              (PP (IN of)
                (NP
                  (NP (JJ NF-κB) (NNS molecules))
                  (PP (IN in)
                    (NP
                      (NP (DT the) (JJ human) (JJ monocytic/macrophage) (NN cell) (NN line))
                      (PRN (-LRB- -LRB-)
                        (NP (NNP THP-1))
                        (-RRB- -RRB-)))))))
            (PP (IN with)
              (NP (JJ opposite) (NNS effects)))
            (, ,)
            (S
              (VP (VBG interfering)
                (PP (IN with)
                  (NP (NN cell) (NN growth)
                    (CC and)
                    (NNS apoptosis)))))))))
    (. .)))

(ROOT
  (S
    (NP (DT These) (NNS observations))
    (VP (MD might)
      (VP (VB provide)
        (NP
          (NP
            (NP (DT a) (JJ further) (JJ biological) (NN link))
            (PP (IN between)
              (NP (NN gender) (NNS effects))))
          (CC and)
          (NP
            (NP (DT the)
              (ADJP (JJ complex) (JJ inflammatory))
              (NN process))
            (VP (VBN involved)
              (PP (IN in)
                (NP (JJ rheumatoid) (NNS synovitis))))))))
    (. .)))

(ROOT
  (S
    (NP (JJ Further) (NNS studies))
    (, ,)
    (S
      (VP (VBG using)
        (NP
          (NP (JJ peripheral) (NNS metabolites))
          (PP (IN of)
            (NP
              (NP (NNS oestrogens))
              (CC and)
              (NP (JJ synovial) (NNS macrophages)))))
        (PP (IN from)
          (NP (NNP RA) (NNS patients)))))
    (, ,)
    (VP (MD might)
      (VP (VB extend)
        (NP
          (NP (DT the) (NN value))
          (PP (IN of)
            (NP (DT these) (NNS observations))))))
    (. .)))

(ROOT
  (NP
    (NP
      (NP (NNP Abbreviations) (NNP DPBS) (NNP =) (NNP Dulbecco) (POS 's))
      (JJ phosphate-buffered) (NN saline))
    (: ;)
    (NP
      (NP
        (NP (NNP E2))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ 17β-oestradiol))))))
      (: ;)
      (NP
        (NP (NNP IFN))
        (SBAR
          (S
            (VP (SYM =)
              (NP (NN interferon))))))
      (: ;)
      (NP
        (NP (NNP IL))
        (SBAR
          (S
            (VP (SYM =)
              (NP (NN interleukin))))))
      (: ;)
      (NP
        (NP (NNP NF))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ nuclear) (NN factor))))))
      (: ;)
      (NP
        (NP (NNP PARP))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ poly-ADP) (NN ribose) (NN polymerase))))))
      (: ;)
      (NP
        (NP (NNP PBS))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ phosphate-buffered) (NN saline))))))
      (: ;)
      (NP
        (NP (NNP PCNA))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ proliferating) (NN cell) (JJ nuclear) (NN antigen))))))
      (: ;)
      (NP
        (NP (NNP RA))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ rheumatoid) (NN arthritis))))))
      (: ;)
      (NP
        (NP (NN THP-1))
        (SBAR
          (S
            (VP (SYM =)
              (NP (JJ cultured) (JJ human) (NNS monocytic/macrophage) (NN cell) (NN line)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (NP (JJ Competing) (NNS interests))
        (NP (DT The) (NN author)))
      (PRN (-LRB- -LRB-) (PRP s) (-RRB- -RRB-)))
    (VP (VBP declare)
      (SBAR (IN that)
        (S
          (NP (PRP they))
          (VP (VBP have)
            (NP (DT no) (VBG competing) (NNS interests))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Authors) (POS '))
      (NNS contributions) (NN MC))
    (VP
      (VP (VBD conceived)
        (NP (DT the) (NN study)))
      (CC and)
      (VP (VBD drafted)
        (NP (DT the) (NN manuscript))))
    (. .)))

(ROOT
  (S
    (NP (NNP SC))
    (VP (VBD participated)
      (PP (IN in)
        (S
          (VP (VBG conducting)
            (NP
              (NP (NN THP-1) (NN cell) (NN growth))
              (CC and)
              (NP (DT the) (JJ functional) (NN assay)))))))
    (. .)))

(ROOT
  (S
    (NP (NNP PM))
    (VP (VBD conducted)
      (NP
        (NP (DT the) (JJ immunocytochemistry) (NN assay))
        (CC and)
        (NP (DT the) (JJ western) (NN blot) (NN assay))))
    (. .)))

(ROOT
  (S
    (NP (NNP PG))
    (VP (VBD conducted)
      (NP
        (NP (DT the) (JJ electrophoretic) (JJ mobility) (NN shift) (NN assay))
        (CC and)
        (NP (DT the) (JJ super) (NN shift) (NN assay))))
    (. .)))

(ROOT
  (S
    (NP (NNP AS))
    (VP (VBD helped)
      (S
        (VP (TO to)
          (VP (VB perform)
            (NP (JJ statistical) (NN analysis))))))
    (. .)))

(ROOT
  (S
    (NP (NNP BV))
    (VP
      (VP (VBD participated)
        (PP (IN in)
          (NP
            (NP (DT the) (NN study) (NN design))
            (, ,)
            (NP (NN coordination)
              (CC and)
              (NNS data) (NN analysis))
            (, ,))))
      (CC and)
      (VP (VBD drafted)
        (NP (DT the) (NN manuscript))))
    (. .)))

(ROOT
  (S
    (NP (DT All) (NNS authors))
    (VP
      (VP (VBD read))
      (CC and)
      (VP (VBD approved)
        (NP (DT the) (JJ final) (NN manuscript))))
    (. .)))

(ROOT
  (S
    (NP (NNP Figure)
      (CC and)
      (NNP Table))
    (VP
      (VP (VBZ captions)
        (NP
          (NP (NNP Figure) (CD 1))
          (: :)
          (NP
            (NP (NN Growth) (NN rate))
            (PP (IN of)
              (NP (DT the) (JJ cultured) (JJ human) (NN THP-1) (NN cell) (NN line)))))
        (PP (IN without)
          (CC or)
          (IN with)
          (NP
            (NP (JJ 17β-oestradiol))
            (PRN (-LRB- -LRB-)
              (NP (NNP E2))
              (-RRB- -RRB-))
            (CC and)
            (NP (NN testosterone))
            (PRN (-LRB- -LRB-)
              (NP (NNP T))
              (-RRB- -RRB-)))))
      (, ,)
      (CC and)
      (VP
        (PP (IN with)
          (NP (NN staurosporine)))
        (PP (IN after)
          (NP (CD 168) (NNS hours)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (DT The) (NN number))
      (PP (IN of)
        (NP
          (NP (JJ recovered) (JJ live) (NNS cells))
          (PP (IN at)
            (NP (JJ different) (NNS times))))))
    (VP (VBD was)
      (VP (VBN evaluated)
        (S
          (VP (VBG using)
            (NP (DT the) (JJ methyl) (NN tetrazolium) (NN salt) (NN reduction) (NN test))))))
    (. .)))

(ROOT
  (S
    (NP (NNS Results))
    (VP (VBP are)
      (VP (VBN expressed)
        (PP (IN as)
          (NP
            (NP (DT the) (JJ mean) (JJ ±) (JJ standard) (NN deviation))
            (PP (IN of)
              (NP (CD five) (JJ different) (NNS experiments)))))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 2))
    (: :)
    (NP
      (NP
        (NP
          (NP (NNP Proliferating) (NN cell) (JJ nuclear) (NN antigen))
          (PRN (-LRB- -LRB-)
            (NP (NNP PCNA))
            (-RRB- -RRB-)))
        (NN expression))
      (PP (IN in)
        (NP (JJ cultured) (JJ human) (NN THP-1) (NN cell) (NN line))))
    (. .)))

(ROOT
  (S
    (LST (-LRB- -LRB-) (DT a) (-RRB- -RRB-))
    (NP
      (NP (VBG Proliferating) (NN cell) (JJ nuclear) (NN antigen))
      (PRN (-LRB- -LRB-)
        (NP (NNP PCNA))
        (-RRB- -RRB-)))
    (VP (VBD expression)
      (PP (IN in)
        (NP (DT the) (JJ cultured) (JJ human) (NN THP-1) (NN cell) (NN line)))
      (PP (IN after)
        (NP (JJ hormonal) (NN treatment))))
    (. .)))

(ROOT
  (S
    (NP (NNS Results))
    (VP (VBP are)
      (VP (VBN expressed)
        (PP (IN as)
          (NP
            (NP (DT the) (JJ mean) (JJ ±) (JJ standard) (NN deviation))
            (PP (IN of)
              (NP
                (NP (DT the) (NN percentage))
                (PP (IN of)
                  (NP
                    (NP
                      (NP (VBG staining) (NN area))
                      (PRN (-LRB- -LRB-)
                        (NP
                          (NP (JJ positive) (NN area))
                          (VP (VBN defined)
                            (PP (IN as)
                              (NP
                                (NP (DT the) (NN number))
                                (PP (IN of)
                                  (NP
                                    (NP (NNS pixels))
                                    (ADJP (JJ detectable)
                                      (PP (IN per)
                                        (NP (NN micron) (NN square))))))))))
                        (-RRB- -RRB-)))
                    (PP (IN for)
                      (NP
                        (NP (CD 100) (NNS cells))
                        (PP (IN in)
                          (NP (CD five) (JJ different) (NNS experiments)))))))))))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Bottom))
    (: :)
    (NP (JJ western) (NN blot) (NN analysis))
    (. .)))

(ROOT
  (NP
    (LST (-LRB- -LRB-) (NN b) (-RRB- -RRB-))
    (NP (NNP PCNA) (NN expression))
    (PP (IN in)
      (NP
        (NP
          (ADJP (JJ untreated) (JJ THP-1))
          (NNS cells))
        (PRN (-LRB- -LRB-)
          (NP (JJ control) (NNP -LSB-) (NN cnt) (NNP -RSB-))
          (-RRB- -RRB-))))
    (. .)))

(ROOT
  (S
    (LST (-LRB- -LRB-) (NN c) (-RRB- -RRB-))
    (VP (VB PCNA)
      (NP
        (NP (NN expression))
        (PP (IN in)
          (NP
            (NP (NN THP-1) (NNS cells))
            (VP (VBN treated)
              (PP (IN with)
                (NP
                  (NP (NN testosterone))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP T))
                    (-RRB- -RRB-))))
              (PP (IN after)
                (NP (CD 168) (NNS hours))))))))
    (. .)))

(ROOT
  (S
    (LST (-LRB- -LRB-) (LS d) (-RRB- -RRB-))
    (VP (VB PCNA)
      (NP
        (NP (NN expression))
        (PP (IN in)
          (NP
            (NP (NN THP-1) (NNS cells))
            (VP (VBN treated)
              (PP (IN with)
                (NP
                  (NP (JJ 17β-oestradiol))
                  (PRN (-LRB- -LRB-)
                    (NP (NNP E2))
                    (-RRB- -RRB-))))
              (PP (IN after)
                (NP
                  (NP (CD 168) (NNS hours))
                  (PRN (-LRB- -LRB-)
                    (NP (NN magnification))
                    (, ,)
                    (NP (NNP ×) (CD 500))
                    (-RRB- -RRB-)))))))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 3))
    (: :)
    (NP
      (NP (NNP Apoptosis) (NN evaluation))
      (PP (IN in)
        (NP (JJ cultured) (JJ human) (NN THP-1) (NN cell) (NN line))))
    (. .)))

(ROOT
  (S
    (LST (-LRB- -LRB-) (DT a) (-RRB- -RRB-))
    (VP (VB Apoptosis)
      (NP
        (NP (NN evaluation))
        (PP (IN in)
          (NP
            (NP (DT the) (JJ cultured) (JJ human) (NN THP-1) (NN cell) (NN line))
            (PP (IN after)
              (NP
                (NP (CD 168) (NNS hours))
                (PP (IN of)
                  (NP (JJ hormonal) (NN treatment))))))))
      (PP (IN without)
        (CC and)
        (IN with)
        (NP (NN staurosporine))))
    (. .)))

(ROOT
  (S
    (NP (NNS Results))
    (VP (VBP are)
      (VP (VBN expressed)
        (PP (IN as)
          (NP
            (NP (DT the) (JJ mean) (JJ ±) (JJ standard) (NN deviation))
            (PP (IN of)
              (NP
                (NP (DT the) (NN percentage) (NN number))
                (PP (IN of)
                  (NP
                    (NP (JJ annexin-positive) (NNS cells))
                    (PP (IN in)
                      (NP (CD five) (JJ different) (NNS experiments)))))))))))
    (. .)))

(ROOT
  (NP
    (LST (-LRB- -LRB-) (NN b) (-RRB- -RRB-))
    (NP (JJ Apoptotic) (NN DNA) (NN evaluation))
    (PP (IN in)
      (NP (NN THP-1) (NNS cells)))
    (PP (IN after)
      (NP
        (NP (CD 168) (NNS hours))
        (PP (IN of)
          (NP (JJ hormonal) (NN treatment)))))
    (PP (IN without)
      (NP
        (ADJP (JJ staurosporine)
          (PP (IN as)
            (NP (NNP detected)))
          (PP (IN by)
            (NP (NN flow) (NN analysis))))
        (JJ cytometry) (NN scatter) (NN analysis)))
    (. .)))

(ROOT
  (NP
    (NP
      (NP (NNP Region) (NNP G))
      (, ,)
      (NP
        (NP (NN control))
        (PRN (-LRB- -LRB-)
          (NP (NN cnt))
          (-RRB- -RRB-))
        (, ,)
        (NP (CD 3.96) (NN %))))
    (: ;)
    (NP
      (NP (JJ 17β-oestradiol))
      (PRN (-LRB- -LRB-)
        (NP (NNP E2))
        (-RRB- -RRB-))
      (, ,)
      (NP (CD 5.54) (NN %)))
    (: ;)
    (NP
      (NP (NN testosterone))
      (PRN (-LRB- -LRB-)
        (NP (NNP T))
        (-RRB- -RRB-))
      (, ,)
      (NP (CD 15.9) (NN %)))
    (. .)))

(ROOT
  (NP
    (LST (-LRB- -LRB-) (NN c) (-RRB- -RRB-))
    (NP (JJ Apoptotic) (NN DNA) (NN evaluation))
    (PP (IN in)
      (NP
        (NP (NN THP-1) (NNS cells))
        (PP (IN after)
          (NP
            (NP (CD 168) (NNS hours))
            (PP (IN of)
              (NP (JJ hormonal) (NN treatment)
                (CC and)
                (NN staurosporine)))))))
    (PRN (-LRB- -LRB-)
      (NP (NNP stau))
      (-RRB- -RRB-))
    (PP (IN for)
      (NP
        (NP (CD 24) (NNS hours))
        (, ,)
        (ADVP (RB as)
          (NP (CD detected))
          (PP (IN by)
            (NP (NN flow) (NN analysis))))
        (NP (JJ cytometry) (NN scatter) (NN analysis))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Region) (NNP G))
    (: :)
    (NP
      (NP (NNS control/S))
      (, ,)
      (NP (CD 18.9) (NN %)))
    (: ;)
    (NP
      (NP (NNP E2/S))
      (, ,)
      (NP (CD 16.5) (NN %)))
    (: ;)
    (NP
      (NP (NNP T/S))
      (, ,)
      (ADJP (CD 24.5) (NN %)))
    (. .)))

(ROOT
  (S
    (ADVP (RB PI))
    (, ,)
    (NP (NN propidium))
    (VP (VBP iodide))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NNP Figure) (CD 4))
      (: :)
      (NP
        (NP (JJ Poly-ADP-ribose) (NN polymerase))
        (PRN (-LRB- -LRB-)
          (NP (NNP PARP))
          (-RRB- -RRB-)))
      (: -))
    (VP (VBD cleaved)
      (NP (NN expression))
      (PP (IN in)
        (NP (JJ cultured) (JJ human) (NN THP-1) (NN cell) (NN line))))
    (. .)))

(ROOT
  (NP
    (NP
      (NP
        (PRN (-LRB- -LRB-)
          (X (SYM a))
          (-RRB- -RRB-))
        (JJ Poly-ADP-ribose) (NN polymerase))
      (PRN (-LRB- -LRB-)
        (NP (NNP PARP))
        (-RRB- -RRB-)))
    (: -)
    (NP
      (NP (JJ cleaved) (NN expression))
      (PP
        (PP (IN in)
          (NP
            (NP (DT the) (JJ cultured) (JJ human) (NN THP-1) (NN cell) (NN line))
            (PP (IN in)
              (NP (JJ basal) (NNS conditions)))))
        (CC and)
        (PP (IN after)
          (NP
            (NP (CD 168) (NNS hours))
            (PP (IN of)
              (NP
                (NP (JJ hormonal) (NN treatment)
                  (CC and)
                  (NN staurosporine))
                (PRN (-LRB- -LRB-)
                  (NP (NNP stau))
                  (-RRB- -RRB-))))))))
    (. .)))

(ROOT
  (S
    (NP (NNS Results))
    (VP (VBP are)
      (VP (VBN expressed)
        (PP (IN as)
          (NP
            (NP (DT the) (JJ mean) (JJ ±) (JJ standard) (NN deviation))
            (PP (IN of)
              (NP
                (NP (DT the) (NN percentage))
                (PP (IN of)
                  (NP
                    (NP (DT the) (JJ positive) (NN area))
                    (PP (IN for)
                      (NP
                        (NP (CD 100) (NNS cells))
                        (PP (IN in)
                          (NP (CD five) (JJ different) (NNS experiments)))))))))))))
    (. .)))

(ROOT
  (NP
    (NP (NNP Bottom))
    (: :)
    (NP
      (NP (JJ western) (NN blot) (NN analysis))
      (VP (VBN related)
        (PP (TO to)
          (NP
            (NP
              (NP (JJ PARP-cleaved) (NN expression))
              (PP (IN in)
                (NP
                  (NP
                    (ADJP (JJ untreated))
                    (NNS cells))
                  (PRN (-LRB- -LRB-)
                    (NP (JJ basal) (NN condition))
                    (-RRB- -RRB-)))))
            (CC and)
            (NP
              (NP (NNS cells))
              (VP (VBN treated)
                (PP (IN with)
                  (NP (NNS hormones)
                    (CC and)
                    (NN staurosporine)))))))))
    (. .)))

(ROOT
  (NP
    (LST (-LRB- -LRB-) (NN b) (-RRB- -RRB-))
    (NP (JJ PARP-cleaved) (NN expression))
    (PP (IN in)
      (NP
        (NP (NN THP-1) (NNS cells))
        (PRN (-LRB- -LRB-)
          (NP (JJ basal) (NN condition))
          (-RRB- -RRB-))))
    (. .)))

(ROOT
  (NP
    (LST (-LRB- -LRB-) (NN c) (-RRB- -RRB-))
    (NP (JJ PARP-cleaved) (NN expression))
    (PP (IN in)
      (NP
        (NP (NN THP-1) (NNS cells))
        (PP (IN after)
          (NP (JJ normal) (NN medium)))))
    (. .)))

(ROOT
  (NP
    (LST (-LRB- -LRB-) (LS d) (-RRB- -RRB-))
    (NP (JJ PARP-cleaved) (NN expression))
    (PP (IN in)
      (NP
        (NP (NN THP-1) (NNS cells))
        (PP (IN after)
          (NP (NNP testosterone)
            (PRN (-LRB- -LRB-)
              (NP (NNP T))
              (-RRB- -RRB-))
            (NN treatment)))))
    (. .)))

(ROOT
  (NP
    (LST (-LRB- -LRB-) (LS e) (-RRB- -RRB-))
    (NP (JJ PARP-cleaved) (NN expression))
    (PP (IN in)
      (NP
        (NP (NN THP-1) (NNS cells))
        (PP (IN after)
          (NP
            (ADJP
              (ADJP (JJ 17β-oestradiol))
              (PRN (-LRB- -LRB-)
                (NP (NNP E2))
                (-RRB- -RRB-)))
            (NN treatment)))))
    (. .)))

(ROOT
  (NP
    (NP (NN cnt))
    (, ,)
    (NP (NN control))
    (. .)))

(ROOT
  (X
    (NP (NN Figure) (CD 5))
    (: :)
    (VP (VBN NF-κB)
      (NP
        (NP (JJ p65) (, ,)
          (ADJP (JJ IκB-α)
            (CC and)
            (JJ phosphorylated))
          (JJ IκB-α)
          (PRN (-LRB- -LRB-)
            (NP
              (QP (CD ser) (CD 32)))
            (-RRB- -RRB-))
          (NN protein) (NN expression))
        (PP (IN in)
          (NP (DT the) (JJ cultured) (JJ human) (NN THP-1) (NN cell) (NN line))))
      (PP (IN after)
        (NP
          (NP (CD 168) (NNS hours))
          (PP (IN of)
            (NP (JJ hormonal) (NN treatment)))))
      (PP (IN without)
        (CC or)
        (IN with)
        (NP (NN staurosporine))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBP are)
      (NP
        (NP (NN representative))
        (PP (IN of)
          (NP (CD four) (JJ separate) (NNS experiments)))))
    (. .)))

(ROOT
  (NP
    (NP
      (NP (NNP CNT))
      (, ,)
      (NP (NN control)))
    (: ;)
    (NP
      (NP (NNP T))
      (, ,)
      (NP (NN testosterone)))
    (: ;)
    (NP
      (NP (NNP E2))
      (, ,)
      (NP (JJ 17β-oestradiol)))
    (. .)))

(ROOT
  (NP
    (NP (NNP Figure) (CD 6))
    (: :)
    (NP
      (NP (JJ Electrophoretic) (JJ mobility) (NN shift) (NN assay))
      (PP (IN for)
        (NP
          (NP (CD NF-κB) (-LRB- -LRB-) (NN arrow) (-RRB- -RRB-))
          (PP (IN in)
            (NP (DT the) (JJ cultured) (JJ human) (NN THP-1) (NN cell) (NN line))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (LST (-LRB- -LRB-) (DT a) (-RRB- -RRB-))
        (NP (JJ Electrophoretic) (JJ mobility) (NN shift) (NN assay))
        (PP (IN for)
          (NP (NNP NF-κB))))
      (PRN (-LRB- -LRB-)
        (NP (NN arrow))
        (-RRB- -RRB-))
      (PP (IN in)
        (NP
          (NP (DT the) (JJ cultured) (JJ human) (NN THP-1) (NN cell) (NN line))
          (PP
            (PP (IN after)
              (NP
                (NP (CD 168) (NNS hours))
                (PP (IN of)
                  (NP (JJ hormonal) (NN treatment)))))
            (CC and)
            (PP (IN without)
              (CC or)
              (IN with))
            (NP
              (NP (NN staurosporine))
              (PRN (-LRB- -LRB-)
                (NP
                  (QP (CD 17) (CD nM)))
                (-RRB- -RRB-)))))))
    (VP (VBZ reveals)
      (NP
        (NP (DT an) (VBN increased) (NN DNA))
        (ADJP (JJ binding)
          (PP (IN in)
            (NP
              (NP (JJ 17β-oestradiol))
              (PRN (-LRB- -LRB-)
                (NP (NNP E2))
                (-RRB- -RRB-))
              (: -)
              (NP (JJ treated) (NNS cells)))))))
    (. .)))

(ROOT
  (S
    (NP
      (NP
        (LST (-LRB- -LRB-) (NN b) (-RRB- -RRB-))
        (NP (JJ Super) (NN shift) (NN assay))
        (PP (IN for)
          (NP (CD p65))))
      (PRN (-LRB- -LRB-)
        (NP (NN arrow))
        (-RRB- -RRB-))
      (PP (IN in)
        (NP
          (NP (DT the) (NNS cells))
          (PP (IN under)
            (NP (DT the) (JJ same) (NNS conditions))))))
    (VP (VBZ confirms)
      (NP
        (NP (DT the) (VBN increased) (NN binding))
        (PP (IN of)
          (NP (CD p65)))
        (PP (IN in)
          (NP (NN E2-treated) (NNS cells)))))
    (. .)))

(ROOT
  (S
    (NP (DT The) (NNS results))
    (VP (VBP are)
      (NP
        (NP (NN representative))
        (PP (IN of)
          (NP (CD four) (JJ separate) (NNS experiments)))))
    (. .)))

(ROOT
  (S
    (NP
      (NP (NN cnt))
      (, ,)
      (NP
        (NP (NN control))
        (: ;)
        (NP (NNP T)))
      (, ,))
    (VP (VBP testosterone))
    (. .)))

(ROOT
  (FRAG
    (NP (CD Table) (CD 1))
    (: :)
    (NP
      (NP (JJ NF-κB) (NN complex))
      (, ,)
      (ADJP (JJ IκB-α)
        (CC and)
        (JJ IκB-α-ser)))
    (: 32)
    (VP (VBN evaluated)
      (PP (IN by)
        (NP (NN immunocytochemistry))))))

